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ABSTRACT 
The spirochete Borrelia burgdorferi is the etiologic agent of Lyme disease. This 
pathogen has a complex enzootic life cycle that involves passage between the tick 
vector (Ixodes scapularis) and various vertebrate hosts with humans being inadvertent 
hosts. There is a pressing need to study the genetic aspects of the B. burgdorferi 
infectious cycle and particularly spirochete genes involved in mammalian infectivity so 
as to develop novel therapeutic and diagnostic strategies to combat Lyme disease. The 
B. burgdorferi genome is fragmented and comprised of a single 900 kb linear 
chromosome and multiple linear and circular plasmids. It has been observed that 
plasmids are lost during serial passage and manipulation in vitro and the loss of some 
of the plasmids has been shown to be related to the loss of infectivity and persistence in 
the host. One such plasmid is linear plasmid 36 (lp36). lp36 is approximately 36kb in 
size and carries 56 putative open reading frames a majority of which have no predicted 
function. B. burgdorferi lacking lp36 show no deficiency in survival in ticks; however, 
these mutant spirochetes are highly attenuated for mammalian infectivity. The genetic 
components of this plasmid that contribute to its function in mammalian infectivity have 
yet to be clearly defined. 
 Using an in vivo expression technology (IVET) based genetic screen the lp36-
encoded gene bbk46 was identified as a candidate B. burgdorferi gene that is 
expressed during mammalian infection. Herein we present evidence that bbk46 is 
required for B. burgdorferi persistent infection of immunocompetent mice. Our data 
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support a molecular model of immune evasion by which bbk46 functions as an RNA to 
regulate expression of the antigenic variation protein VlsE. These data represent the 
first demonstration of a regulatory mechanism critical for controlling vlsE gene 
expression. Moreover these findings further define the critical role of linear plasmid 36 in 
Borrelia burgdorferi pathogenesis.  
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CHAPTER ONE: INTRODUCTION 
The following chapter provides an introduction to Lyme disease, its causative 
agent Borrelia burgdorferi and the unique genetic features of this pathogen. It also 
introduces the fundamental basis of this study, which was aimed at elucidating the 
genetic components of linear plasmid 36 that make a contribution toward the essential 
role of this plasmid in B. burgdorferi mammalian infectivity.  
1.1: Borrelia burgdorferi Is The Causative Agent Of Lyme Disease.  
In 1975, a group of children in Lyme, Connecticut diagnosed with an unusual 
form of juvenile arthritis sparked off an investigation that led to the discovery of a 
disease that is known today as Lyme borreliosis or Lyme disease [1]. It is now 
considered to be the most prevalent arthropod-borne bacterial disease in the world. 
According to the Centers for Disease Control and Prevention (CDC) an average of 
about 20,000 to 30,000 cases are reported every year in the United States with the 
major prevalence in the northeastern states [2]. Though Lyme disease has never been 
reported as fatal it can be severely debilitating if left undiagnosed and untreated. The 
early symptoms include the tell-tale "bull’s eye" skin rash termed erythema migrans 
accompanied by aches, fever and nausea. Antibiotic treatment at this, early localized, 
stage is effective in eliminating the infection. However, untreated infections lead to a 
complex disease affecting several organs including the skin, joints, heart and nervous 
system [1]. 
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The etiologic agent of this disease was identified as the spirochete Borrelia 
burgdorferi by Dr. William Burgdorfer in 1982 [1]. Spirochetes are a phylum of Gram-
negative bacteria that are characterized by their spiral shape and axial, periplasmic 
flagella [3]. The genus Borrelia includes several medically relevant species causing 
diverse diseases including Lyme disease, syphilis, leptospirosis, relapsing fever and 
periodontitis. The species associated with Lyme disease are Borrelia burgdorferi, B. 
garinii and B. afzelii, together called Borrelia burgdorferi sensu lato [1, 4, 5].  
Borrelia burgdorferi has a complex enzootic life cycle that involves passage 
between the tick vector (Ixodes scapularis) and various vertebrate hosts (Fig. 1) [6]. The 
tick larvae can acquire spirochetes when they feed on infected animals, usually small 
mammals such as mice and squirrels. The spirochetes survive within the tick midgut as 
the ticks overwinter and then are transferred to other, larger, mammalian hosts when 
the ticks take their next blood meal. Humans become infected with B. burgdorferi via the 
bite of an infected Ixodes tick and are incidental hosts of these spirochetes. Although 
the spirochetes can be transferred to humans through tick bites, naive ticks cannot 
acquire spirochetes from an infected human. As a result, humans are termed as “dead 
end hosts” for B. burgdorferi and are not part of the natural enzootic life cycle of the 
spirochete. [1].  
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 Figure 1: Natural enzootic life cycle of Borrelia burgdorferi. 
Spirochetes are transferred between the Ixodes spp. tick vector and mammalian hosts, 
which include small rodents and deer. Humans are not part of this natural life cycle and 
only acquire these spirochetes accidentally when they get bitten by infected ticks.  
 
1.2: The Unique Segmented B. burgdorferi Genome. 
Borrelia species are unique compared to other bacteria due to the presence of a 
fragmented genome [7, 8]. The B. burgdorferi genome is comprised of a single small 
linear chromosome that is about 900 kb in size along with 12 linear and 9 circular 
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plasmids ranging in size from 5 kb to 56 kb (Fig. 2). The genome also has a very low 
G+C content of approximately 28% [1]. Comparative genomics studies have revealed 
that the chromosomes of B. burgdorferi isolates have relatively constant gene content 
and organization and carry mostly housekeeping genes. Conversely, the plasmids have 
been found to be more variable between isolates and carry genes for several surface 
proteins that interact with the tick or mammalian host and show differential expression in 
the two environments [1]. The genetic composition of the plasmids is quite intriguing. 
Even though approximately 40% of the B. burgdorferi genome is composed of plasmids, 
less than 10% of the plasmid-encoded genes have any known function [7-9]. Also, a 
majority of the annotated pseudogenes in the genome are located on the plasmids and 
not on the chromosome [9]. Another unusual finding is the presence of multiple 
prophage plasmids within a single cell, since traditionally, prophages have been known 
to prevent the integration of additional incoming bacteriophages into the host genome 
allowing only one to be integrated and expressed at a time [1, 10, 11]. It has been 
observed that plasmids are lost during serial passage and manipulation in vitro and the 
loss of some of the plasmids, like lp28-1 and lp25, has been shown to be related to the 
loss of infectivity and persistence in the host [12-15]. Another plasmid that is essential 
for B. burgdorferi mammalian infectivity is linear plasmid 36 (lp36) [16]. 
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 Figure 2: Schematic representation of the segmented genome of B. burgdorferi. 
The genome of Borrelia burgdorferi contains one chromosome, 12 linear and 9 to11 
circular plasmids. The chromosome is about 900 kilobases (kb) in size while the 
plasmids range in size from 5 kb to 56 kb. 
 
1.3: Linear Plasmid 36 
Lp36 is approximately 36 kb in size and carries 56 putative open reading frames 
majority of which have no predicted function [7, 8, 17]. It has been observed that this 
plasmid is rarely lost among natural isolates [18]. Sequence variation has been 
observed between different strains of B. burgdorferi in the region extending from bbk35 
to bbk50 on lp36 and the presence of this region has been associated with clones 
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demonstrating more severe disseminated infection [15, 19, 20]. Mutant B. burgdorferi 
lacking lp36 show no deficiency in survival in ticks; however, these spirochetes do not 
readily survive in the mammalian host [16]. The ID50 of a lp36− clone was found to be 
about 108 spirochetes as compared to 103 for wild-type spirochetes, which indicates that 
this plasmid is critical for B. burgdorferi mammalian infectivity [21]. 
 Even though it is known that lp36 is required for the spirochetes to survive within 
the host, there is very little known about the lp36-encoded genes that contribute to this 
essential function. Apart from a few lipoproteins, bbk07 and bbk50 that have putative 
immunogenic functions [22-25] few other genes had been found to have any known 
functions. During the course of our research, Lin et al. (2012) published their work 
analyzing a comprehensive signature tagged mutagenesis (STM) mutant library in B. 
burgdorferi with the aim of identifying gene candidates important for infectivity [26]. This 
study identified that mutants with disruptions in the genes located in the region from 
bbk02.1 to bbk04 and genes bbk05, bbk07, bbk13, bbk17, bbk45, bbk46 to bbk50 on 
lp36 showed reduced mammalian infectivity. The two lp36-encoded genes that have 
been studied most extensively for their possible roles in infectivity are bbk32 and bbk17. 
The bbk32 gene encodes a fibronectin binding protein that is believed to be involved in 
motility and dissemination of the spirochetes from the site of the tick bite through the 
extracellular spaces to different tissues and organs [27-32]. The bbk17 gene encodes 
an adenine deaminase, a 548 amino acid enzyme involved in conversion of adenine to 
hypoxanthine, a critical step in the B. burgdorferi purine salvage pathway for the 
synthesis of DNA and RNA [8, 16]. Both of these genes have been studied separately 
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and each has been found to have a minor contribution to mammalian infection [21, 26, 
31-33]. The increase in the ID50 for spirochetes lacking either gene; however, was much 
lower than that seen due to the loss of the entire linear plasmid 36 [16, 32]. Thus the 
essential role of lp36 in mammalian infectivity is partially, but not entirely, attributed to 
each of these genes. Moreover, as suggested by the work of Lin et al. (2012), there are 
likely additional genes on lp36 that contribute to the role of this plasmid in B. burgdorferi 
pathogenesis. 
1.4: Gene Regulation And Differential Expression. 
Borrelia burgdorferi survive within highly dissimilar environments during their life 
cycle. They exist in the insect vector, Ixodes scapularis, and then through the bite of the 
tick they enter into the mammalian host. The spirochetes encounter changes in the 
environmental temperature, pH and availability of nutrients and are required to evade 
the host immune response. They have developed highly complex regulatory 
mechanisms by which they manipulate the expression of various metabolic and 
antigenic factors in order to survive [34-51]. 
The regulation of gene expression in Borrelia burgdorferi is a highly complex 
process involving various genes (Table 1). The major regulator of expression of 
virulence genes in B. burgdorferi is the alternative sigma factor RpoS which has been 
shown to be essential for mammalian infectivity [52]. RpoD and RpoS are believed to be 
involved in regulation of genes during tick colonization [1].    
7 
 
Table 1:Genes invovled in gene regulation in Borrelia burgdorferi. 
Gene Description Reference 
rpoS Sigma S [51] 
rpoN Sigma 54 [51] 
rrp2 Response regulator [51] 
hk Histidine kinase [51] 
ntrC Nitrogen regulatory protein C [51] 
pta Phosphate acetyltransferase [51] 
bosR Borrelia oxidative stress regulator [51] 
csrA Carbon storage regulator A [51] 
dsrA Downstream region A [51] 
hfq Host factor required for Qβ bacteriophage replication [51] 
rpoD Sigma-70 [53, 54] 
ebfC (ybaB) DNA-Binding protein [51, 55] 
bpaB (parB) DNA-binding protein [51, 55, 56] 
 
The blood meal taken by the tick is believed to trigger a cascade of events that 
involves the repression of phosphate acetyltransferase (Pta) by the carbon storage 
regulator A (CsrA) resulting in the generation of acetyl phosphate which is believed to 
activate the response regulator Rrp2 subsequently resulting in the activation of sigma 
factor RpoS via activated RpoN [51, 57-59]. The RpoN-RpoS pathway remains 
activated during the mammalian infection and together these two factors form a 
regulatory cascade that controls the expression of several genes during the enzootic life 
cycle. BosR is another gene implicated as a regulator of RpoS and believed to be 
essential for mammalian infectivity but not for survival in the tick [51, 60, 61]. BosR has 
also been shown to regulate the expression of some genes in an independent manner 
exclusive of the RpoN-RpoS pathway [62]. DsrABb is a small RNA (sRNA) involved in 
the temperature mediated regulation of RpoS expression [51]. Ebfc and BpaB are 
believed to bind to upstream regions of erp (ospE, ospF and elp) genes and regulate 
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their expression [56, 63-65]. Two of the best studied antigenic factors controlled by the 
RpoN-RpoS pathway are the outer surface proteins OspC and OspA encoded on the 
circular plasmid 26 and linear plasmid 54, respectively [66]. OspA is required for 
survival in the tick and shows increased expression while the spirochetes are in the tick; 
whereas, OspC plays a critical role in spirochete migration from the tick mid-gut and the 
initial establishment of a mammalian infection [47, 48, 67, 68] and its expression 
increases as spirochetes migrate out of the tick into the mammal. Other genes known to 
be of importance during tick colonization of B. burgdorferi are bbe16, bb0365 and 
bb0690 [69-71]. 
There are several other genes that also show differential expression during the 
mammalian phase of the spirochete lifecycle whose regulation can be rather complex 
and whose exact function is not always understood (Table 2) [51]. CRASPs 
(complement regulator-acquiring surface proteins) are a group of proteins that bind to 
host extracellular proteins and plasminogen and are believed to play a role 
dissemination [72]. bbk32 is a fibronectin binding protein which is believed to be 
involved in dissemination within the mammalian host [27-32]. RevA is another 
fibronectin binding protein that was found to have antigenic properties [73]. The purine 
salvage pathway genes bbk17, guaA and guaB have been shown to be critical for 
survival in the mammalian host [16, 74]. The purine transporters BBB22 and BBB23 
play a vital role in mammalian infectivity as well [75].  
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Table 2: Genes known to be expressed in the mammalian host. 
Gene Predicted/ deduced gene product Reference 
BB0036 DNA topoisomerase 4 (pare) [76] 
BB0056 Phosphoglycerate kinase [22] 
BB0096 V-type ATPase subunit E, putative [76] 
BB0108 Peptidylprolyl isomerase [22] 
BB0134 Hypothetical Protein [76] 
BB0147 Flagellar filament (FlaB) [22, 77-79] 
BB0181 Flagellar hook-associated protein (FlgK) [22] 
BB0215 Phosphate ABC trasporter (PstS) [22] 
BB0238 Hypothetical Protein [22] 
BB0260 Hypothetical Protein [22] 
BB0279 Flagellar protein (FliL) [22] 
BB0283 Flagellar hook protein (FlgE) [22] 
BB0286 Flagellar protein (FlbB) [22] 
BB0323 Hypothetical Protein [22, 79] 
BB0328 Oligopeptide ABC transporter (OppA-1) [22, 79] 
BB0329 Oligopeptide ABC transporter (OppA-2) [22, 79] 
BB)330 Oligopeptide ABC transporter (OppA-3) [79] 
BB0337 Enolase [22] 
BB0348 Pyruvate kinase [22] 
BB0359 Carboxyl-terminal protease [22] 
BB0365 Lipoprotein LA7 [22, 79] 
BB0383 Basic membrane protein A (BmpA)  [79] 
BB0385 Basic membrane protein D (BmpD) [22] 
BB0408 Phosphotransferase system, fructose-
specific IIABC 
[22] 
BB0476 Translation elongation factor TU (tuf) [22] 
BB0518 Molecular chaperone (DnaK) [22] 
BB0543 Hypothetical Protein [22] 
BB0560 Hsp90 [79] 
BB0565 Purine binding chemotaxis protein (CheW-2) [76] 
BB0567 Chemotaxis histidine kinase (CheA-1) [76] 
BB0603 P66 outer membrane protein [22, 79-81] 
BB0649 Chaperonin (GroEL) [22] 
BB0652 Protein export protein (SecD) [22] 
BB0668 Flagellar filament outer layer protein (FlaA) [22] 
BB0669 Chemotaxis histidine kinase (CheA-2) [76] 
BB0681 Methyl-accepting chemotaxis protein (Mcp-
5) 
[22, 76] 
BB0741 Chaperonin (GroES) [76] 
BB0751 Hypothetical Protein [22] 
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Gene Predicted/ deduced gene product Reference 
BB0772 Flagellar P-ring protein (FlgI) [22] 
BB0774 Flagellar basal body cord protein (FlgG) [22] 
BB0805 Polyribonucleotidyltransferase (PnpA) [22] 
BB0811 Hypothetical Protein (COG1413) [22] 
BB0844 Hypothetical Protein [22, 76] 
BBA03 Hypothetical Protein [22, 79] 
BBA04 “S2 antigen” [22] 
BBA07 Hypothetical Protein [22] 
BBA15 Outer surface protein A [22, 82] 
BBA16 Outer surface protein B [22, 82] 
BBA19 Hypothetical Protein [22] 
BBA25 Decorin binding protein B (DbpB) [22, 76, 83] 
BBA34 Oligopeptide ABC transporter (OppA-5) [22] 
BBA36 Lipoprotein [22, 76] 
BBA40 Hypothetical protein [22] 
BBA48 Hypothetical protein [22] 
BBA57 Hypothetical protein [22] 
BBA64 Hypothetical protein (P35) [22, 79] 
BBA66 Hypothetical protein [22, 79] 
BBA72 Hypothetical protein [76] 
BBA73 “P35”  [76] 
BBB09 Hypothetical protein [22] 
BBB14 Hypothetical protein [22] 
BBB16 Oligopeptide ABC transporter (OppA-4) [22] 
BBB17 GuaA [74] 
BBB18 GuaB [74] 
BBB19 OspC  [22, 47, 48, 67, 76, 84] 
BBB22 Purine transport protein [75] 
BBB23 Purine transport protein [75] 
BBC03 Hypothetical protein [22] 
BBC06 EppA (BapA) [22] 
BBC10 RevA [22] 
BBE09 Hypothetical protein [22] 
BBF03 BdrS (BdrF1) [22] 
BBF33 VlsE [22, 85, 86] 
BBG18 Hypothetical protein [22] 
BBG33 BdrT (BdrF2) [22] 
BBH06 Hypothetical protein [22] 
BBH13 BdrU (BdrF3) [22] 
BBI36/38 Hypothetical Protein [79] 
BBI42 Hypothetical protein [22] 
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Gene Predicted/ deduced gene product Reference 
BBJ23 Hypothetical protein [76] 
BBJ24 Hypothetical protein [22] 
BBJ31 Hypothetical protein [76] 
BBJ51 VlsE1 (authentic frame shift) [76] 
BBK07 Hypothetical protein [22] 
BBK12 Hypothetical protein [22] 
BBK13 Hypothetical protein (COG2859) [22] 
BBK17 Adenine deaminase [16] 
BBK19 Hypothetical protein [22] 
BBK23 Hypothetical protein [22] 
BBK32 Fibronectin-binding protein [22, 29, 87] 
BBK50 Putative P37 antigenfamily lipoprotein [88] 
BBK52 “P23”, putative lipoprotein [22] 
BBK53 Hypothetical protein [22] 
BBL03 Hypothetical protein [22] 
BBL15 Hypothetical protein [76] 
BBL27 BdrO (BdrE1) [22] 
BBL39 ErpN (CRASP-5) [22, 79] 
BBL40 ErpO [22, 76, 79] 
BBM27 RevA [22, 79] 
BBM34 BdrK (BdrD2) [22] 
BBM36 Hypothetical protein [22] 
BBN11 Hypothetical protein [22] 
BBN27 BdrR (BdrE2) [22] 
BBN28 MlpL [22] 
BBN34 BdrQ (BdrD10) [22] 
BBN38 ErpP (CRASP-3) [22, 79] 
BBN39 ErpQ [22] 
BBO34 BdrM (BdrD3) [22] 
BBO39 ErpL [22] 
BBO40 ErpM [22] 
BBP34 BdrA (BdrD4) [22] 
BBP39 ErpB [22] 
BBQ03 Hypothetical protein [22] 
BBQ04 Hypothetical protein [22] 
BBQ13 Hypothetical protein [22] 
BBQ19 Hypothetical protein [22] 
BBQ34 BdrW (BdrE6) [22] 
BBQ35 MlpJ [22] 
BBQ40 Partition protein [22] 
BBQ42 BdrV (BdrD5) [22] 
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Gene Predicted/ deduced gene product Reference 
BBR12 Hypothetical protein [22] 
BBR35 BdrG [22] 
BBR42 ErpY [22] 
BBS30 MlpC [22] 
BBS41 ErpG [22] 
 
1.5: B. burgdorferi Immune Evasion Strategies. 
Evasion of the host immune response is one of the major mechanisms of survival 
within the mammalian host. The Erp lipoproteins are expressed during murine infection 
and are believed to bind to the host complement inhibitory factor H thereby providing 
protection from the host immune response [44]. Lmp1 is a surface exposed antigen 
believed to provide protection against host immunity [89]. The outer surface antigenic 
protein VlsE undergoes random recombination between its central locus and the 
adjacent silent cassettes, which gives rise to protein products of varying sequences 
being presented at the cellular surface. This mechanism of generating antigenic 
variation is believed to be essential for long term survival of spirochetes within the 
mammalian host and occurs at different time points during the mammalian infection 
creating differences in the antigenic profile of the spirochete surface and aiding in host 
immune evasion [13, 14, 18, 85, 86, 90-93].  
1.5: Methods to Identify Genes Expressed In Vivo. 
The unique nature of the B. burgdorferi genome with its segmented structure and 
high A/T content, its lack of stability and loss of plasmids during in vitro passage have 
hampered the experimental study of this organism. The biggest challenge for the 
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genetic manipulation of these spirochetes has been its extremely low transformability 
that make mutagenesis and subsequent complementation difficult [94]. The first 
genetically defined mutants were generated a number of years after the initial discovery 
of B. burgdorferi as the causative agent of Lyme disease [95-97]. Since those early 
days, molecular genetic tools have been developed and utilized extensively to better 
understand the mechanisms underlying the survival and pathogenesis of this organism. 
B. burgdorferi have been grown in vitro under varying conditions of temperature and pH, 
that are believed to duplicate those found in the tick or the mammal and they have been 
subjected to DNA microarrays and proteomic analyses in order to determine the 
changes in gene expression that are observed under these different environmental 
conditions [98-100]. Another method used to study B. burgdorferi gene expression in 
response to the mammalian host environment is the growth of spirochetes in dialysis 
membrane chambers (DMCs) within the peritoneal cavity of rats [76, 101-103]. In vivo 
expression technology (IVET) has been used to identify novel genes that are expressed 
within a microbe while it is present in a host or a particular experimental environment 
[104, 105]. In this system a virulence and/or growth essential gene within a microbe is 
deleted, thus creating a clone that is incapable of surviving within the environment of 
interest. A genomic library of DNA fragments is then cloned upstream of the essential 
gene. The fragments of the genome that carry promoters that are active in vivo will drive 
the expression of the essential gene and will be selected by the host environment 
because only those clones with transcriptionally active promoters will be able to survive 
in the host. This method has been used to identify novel virulence genes in several 
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pathogenic organisms [106-110] but has not yet been used to identify virulence factors 
in Borrelia burgdorferi.  
1.6: Hypothesis 
We hypothesize that, though there are some known contributors to the effects of 
lp36 on B. burgdorferi pathogenesis in mammalian hosts, there are possibly additional, 
as of yet unknown, genes on lp36 that also contribute towards the essential role of this 
plasmid in mammalian infectivity. Using an in vivo genetic screen we will generate a list 
of candidate genes expressed in vivo that can be further investigated for virulence 
functions. 
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CHAPTER TWO: IN VIVO EXPRESSION TECHNOLOGY IDENTIFIES A 
NOVEL VIRULENCE FACTOR CRITICAL FOR BORRELIA 
BURGDORFERI PERSISTENCE IN MICE. 
2.1: Introduction 
Lyme disease is a multi-stage inflammatory disease caused by the pathogenic 
spirochete Borrelia burgdorferi, which is transmitted by the bite of an infected tick [6].  B. 
burgdorferi has an enzootic life cycle that requires persistence in two disparate 
environments, the arthropod vector and the mammalian host. B. burgdorferi is well 
adapted to modulate its expression profile in response to the different conditions 
encountered throughout its infectious cycle [51]. Although the specific environmental 
signals that induce changes in spirochete gene expression are not fully defined, it has 
been reported that changes in temperature, pH, the presence or absence of mammalian 
blood, as well as changes in bacterial growth rate, can affect patterns of gene 
expression [51, 76, 98-100, 102, 111]. DNA microarray analysis and proteomics have 
been used to examine changes in the global expression profile of B. burgdorferi grown 
under in vitro conditions that partially mimic the tick and mouse environments [98-100]. 
A rat dialysis membrane chamber (DMC) implant model, together with microarray 
technology, has been used to help identify B. burgdorferi genes expressed in response 
to mammalian host-specific signals [76, 101-103]. Although the data reported in these 
studies provide insight into the molecular mechanisms of gene regulation, they may not 
fully reflect the patterns of B. burgdorferi gene expression during an active mammalian 
infection. Furthermore, transcriptome analysis of B. burgdorferi during murine infection 
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has proven difficult given that spirochete loads in the blood and tissues are too low to 
recover sufficient spirochete RNA for direct microarray analysis [42].   
In vivo expression technology (IVET) is a gene discovery method used to identify 
transcriptionally active portions of a microbial genome during interaction of the 
microorganism with a particular environment or host organism [104, 105]. In this 
system, the environment itself directly selects for upregulated bacterial loci [110]. The 
IVET selection system functions on the premise that deletion of a biosynthetic gene can 
lead to attenuation of growth and persistence of a pathogen in the host environment.  
This attenuation can be complemented by expression of the biosynthetic gene driven by 
promoters that are transcriptionally active in vivo.  Thus, in the environment of interest, 
in vivo transcriptionally active promoters can be selected from a genomic library of DNA 
fragments cloned upstream of the essential biosynthetic gene [104, 105, 107, 110]. 
IVET is a sensitive and versatile method for identification of in vivo-expressed genes 
that has been used with pathogenic bacteria and fungi in a wide variety of host 
environments and has identified a number of previously uncharacterized virulence 
genes [106-110]. 
Using IVET we have developed and applied a genome-wide genetic screening 
approach to identify B. burgdorferi genes that are expressed during an active murine 
infection. This is the first time that an IVET strategy has been applied to B. burgdorferi. 
Moreover, we have identified a novel gene on virulence plasmid lp36 that is strongly 
induced in vivo and required for B. burgdorferi persistent infection in the mouse. 
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2.2: Results 
2.2.1: Mammalian Host Adapted Spirochetes Demonstrate A 100-Fold Decrease In 
ID50 Relative To In Vitro Grown Spirochetes. 
 It is clear that B. burgdorferi modulates its gene expression profile at different 
stages of the infectious cycle [51]. The infectious dose of wild-type B. burgdorferi varies 
depending on the environment from which the spirochetes are derived. For example, 
the 50% infectious dose (ID50) of spirochetes derived from partially fed ticks has been 
found to be two orders of magnitude lower than that of log phase in vitro grown B. 
burgdorferi [112]. In order to quantitatively assess the impact that adaptation to the 
mammalian environment has on B. burgdorferi infectivity the 50% infectious dose (ID50) 
of spirochetes derived directly from the mammalian host was determined and compared 
to that of log phase in vitro grown spirochetes. B. burgdorferi are only transiently 
present in the blood of immunocompetent mice [113], whereas spirochetes persist 
longer in the blood of immunocompromised mice [114]. Therefore, the blood of severe 
combined immunodeficiency (scid) mice infected with B. burgdorferi was used as a 
source of spirochetes adapted to the mammalian environment. Strikingly, an inoculum 
containing approximately eight in vivo-derived spirochetes was able to infect five out of 
six mice, whereas, 5,000 in vitro grown spirochetes were required to obtain this level of 
infectivity (Table 3). 
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Table 3: In vivo-adapted B. burgdorferi are highly infectious. 
In vivo grown spirochetes In vitro grown spirochetes 
Spirochete 
dose 
Number of mice infecteda/ 
number of mice analyzed 
Spirochete 
dose 
Number of mice infecteda/ 
number of mice analyzed 
8x102 6/6 5x104 6/6 
8x101 6/6 5x103 6/6 
8x100 5/6 5x102 2/6 
  5x101 1/6 
  5x100 0/6 
    
ID50b < 8 spirochetes ID50b 660 spirochetes 
aMouse infection was determined 3 weeks post inoculation by serological response to 
B. burgdorferi proteins and reisolation of spirochetes from ear, bladder and joint tissues. 
bThe ID50 was calculated according to method of Reed and Muench [115]. 
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The ID50 for in vivo-derived spirochetes was found to be less than eight organisms. In 
contrast, the ID50 for in vitro grown spirochetes was calculated to be 660 organisms. 
These data indicate that mammalian host-adapted spirochetes are 100-fold more 
infectious than in vitro grown spirochetes, likely due to appropriate coordinate 
expression of in vivo-expressed genes important for murine infectivity.   
2.2.2: The B. burgdorferi IVET System Is A Robust Method For Selection Of B. 
burgdorferi Sequences That Are Expressed During Murine Infection. 
We have developed a genome-wide genetic screening method to identify B. 
burgdorferi genes that are expressed during mouse infection using an in vivo 
expression technology (IVET) approach [104, 105]. The in vivo expression technology 
vector, pBbIVET, carries the B. burgdorferi bmpB Rho-independent transcription 
terminator sequence [116] repeated in triplicate (3XTT), to prevent any read-through 
promoter activity from the pBSV2* Borrelia shuttle vector backbone, followed by the 
promoter-less in vivo-essential pncA gene (Figure 3) [12, 117]. Spirochetes lacking 
linear plasmid (lp) 25 are non-infectious in mice and severely compromised in the tick 
vector [13, 14, 18, 118-121]. The pncA gene, located on lp25, encodes a 
nicotinamidase that is sufficient to restore murine infectivity to B. burgdorferi lacking the 
entire lp25 plasmid [12]. Genetic transformation of low-passage, infectious B. 
burgdorferi occurs at low frequency and efficiency hampering introduction of a complex 
DNA library into an infectious background [122, 123].  Because B. burgdorferi clones 
lacking lp25 and lp56 demonstrate increased transformability [124], we isolated a clonal 
derivative of the low-passage infectious clone A3 that lacks both lp25 and lp56. This 
clone was designated A3 68-1 [125]. Clones A3 and A3 68-1 were transformed by 
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electroporation with 20 µg of a Borrelia shuttle vector. The transformation frequency and 
efficiency of A3 68-1 was determined relative to that of the A3 parent.  As expected, 
genetic transformation of A3 68-1 occurred at a high frequency and efficiency.  We 
recovered approximately 2,000 transformants/ml in clone A3 68-1, whereas no 
transformants were recovered with a parallel transformation of clone A3 (data not 
shown).  In order to test the function of the B. burgdorferi IVET system, the promoter for 
the in vivo essential ospC gene [126], was cloned in front of the promoter-less pncA 
gene in pBbIVET (Figure 3), creating plasmid pBbIVET-ospCp.  This plasmid, along with 
pBbIVET alone, was transformed into the non-infectious, low-passage, highly 
transformable B. burgdorferi clone A3 68-1. All clones were tested for their abilities to 
infect groups of 6 C3H/HeN mice at an infectious dose 100 (ID100) of 1x104 spirochetes 
[16], indicating the presence or absence of an active promoter sufficient to drive 
expression of pncA thereby restoring infectivity. Spirochetes were reisolated from the 
ear, bladder and joint tissues of 5/6 mice infected with B. burgdorferi harboring 
pBbIVET-ospCp. No spirochetes were reisolated from mice (0/6) infected with B. 
burgdorferi carrying the promoter-less pBbIVET alone. Together these data 
demonstrated that our promoter trap system functioned with a known in vivo active 
promoter. 
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 Figure 3: Schematic representation of the pBbIVET vector. 
Features of this vector include: 3XTT, the transcriptional terminator sequence for bmpB 
[116] repeated in triplicate; pncA, promoterless pncA gene; flgBpkan, kanamycin 
resistance cassette; zeo, zeocin resistance marker; ColE1, E. coli origin of replication; 
ORFs 1, 2, 3, B. burgdorferi cp9 replication machinery.  The EcoRI restriction site was 
used to clone the B. burgdorferi control in vivo-expressed promoter, ospCp, as well as 
the B. burgdorferi (Bb) gDNA library, in front of the promoterless pncA gene. The 
pBbIVET vector was derived from the B. burgdorferi shuttle vector pBSV2* [127]. 
 
2.2.3: Screening For B. burgdorferi Genes Expressed During Murine Infection. 
A B. burgdorferi genomic DNA library using an average DNA fragment size of 
approximately 200 bps was constructed upstream of the promoter-less pncA gene 
(Figure 1) in the pBbIVET vector in E. coli, yielding approximately 30,000 independent 
clones. A small subset of individuals from the 30,000 clone library in E. coli was 
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analyzed by PCR and DNA sequencing and determined to carry non-identical B. 
burgdorferi DNA fragments.  The strategy used to construct the pBbIVET library allowed 
the DNA fragments to be cloned in either the forward or reverse orientation relative to 
the pncA gene. Therefore, a library of 30,000 clones each harboring a unique 200 bp 
DNA fragment represented approximately 2X coverage of the 1.5 Mb genome of B. 
burgdorferi. Although the initial analysis of the transformation efficiency of B. burgdorferi 
clone A3 68-1 demonstrated that each transformation of 20 μg of a single purified 
plasmid into this genetic background yielded approximately 10,000 transformants, this 
transformation efficiency was not achieved when 20 μg of complex library plasmid DNA 
was transformed into A3 68-1. Forty four transformations of the library plasmid DNA 
resulted in recovery of approximately 15,000 individual clones in B. burgdorferi A3 68-1, 
representing an IVET library in B. burgdorferi with approximately 1X coverage of the 
spirochete genome. As described for the pBbIVET library in E. coli, a subset of 
individuals from 15,000 clone library in B. burgdorferi were analyzed and found to carry 
non-identical B. burgdorferi DNA fragments.   
Like the BbIVET system described here, many IVET strategies are based upon 
complementation of auxotrophy. For microorganisms other than B. burgdorferi these 
strategies have allowed negative selection against “promoter-less” clones in minimal 
medium in which the auxotroph mutants are unable to grow [128]. B. burgdorferi lacking 
pncA are not attenuated for growth in the complex, undefined B. burgdorferi medium, 
BSKII.  Moreover, there is currently no minimal medium available that supports the 
growth of wild-type B. burgdorferi. Therefore, the BbIVET system did not include 
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negative selection against “promoter-less” clones in vitro. 179 mice were infected with 
pools from the B. burgdorferi IVET library of approximately 100 clones each, with each 
clone at a dose of 1x104 spirochetes resulting in a total dose of 1x106 spirochetes per 
mouse. Three weeks post inoculation, mice were sacrificed and ear, heart, bladder and 
joint tissues were harvested for reisolation of infectious spirochetes. 175 out of 179 mice 
became infected with B. burgdorferi as determined by reisolation of spirochetes from at 
least two or more of the tissue sites analyzed (Table 4). However, due to the potentially 
stochastic nature of the kinetics of infection [129] and/or tissue-specific promoter activity 
of distinct B. burgdorferi genomic fragments not all four tissue sites from all 175 infected 
mice were found to be positive for spirochete reisolation. Nonetheless, the recovery of 
live spirochetes from infected mouse tissues suggested that these spirochetes harbored 
in vivo active promoter(s) in the pBbIVET plasmid sufficient to drive expression of the in 
vivo-essential pncA gene to restore spirochete mouse infectivity.  
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Table 4: The B. burgdorferi IVET system selects for in vivo active promoters. 
Number of 
BbIVET clones 
screened 
Positive reisolation of infectious 
spirochetes from mouse tissuesa 
Number of unique 
genomic fragments 
recovered 
 Ear Heart Bladder Joint  
~15,000 175 /179 173/179 172/179 174/179 289 
aNumber of mice positive for spirochete reisolation/ number of mice analyzed.  Four 
mice were reisolate-negative for all tissues analyzed. Three mice were reisolate-
negative for the bladder tissue. One mouse was reisolate-negative for the heart and 
joint tissues.  One mouse was reisolate-negative for the heart tissue. 
26 
 
 Total genomic DNA was isolated from each pool of reisolated spirochetes from 
each of the four mouse tissues and the pBbIVET plasmid DNA rescued in E. coli. 
Colony PCR using primers targeting the genomic DNA insert region of the pBbIVET 
vector was performed on 24 of the resulting E. coli colonies from each plasmid rescue 
transformation. No reisolated spirochetes were found to harbor a pBbIVET plasmid 
lacking a genomic DNA fragment insert. The amplified inserts were analyzed by 
restriction digest using a cocktail of the A/T-rich restriction enzymes to identify those 
DNA fragments with distinct restriction patterns, suggesting that these fragments 
represent different in vivo active promoters. Up to eleven non-identical restriction digest 
patterns were detected for every subset of 24 E. coli transformants carrying pBbIVET 
DNA that were analyzed (Fig. 4). The DNA fragments corresponding to each distinct 
restriction digest pattern were further analyzed by DNA sequencing and the identities of 
the sequences determined by microbial genome BLAST analysis. Screening of 
approximately 15,000 BbIVET clones through mice resulted in the identification of 289 
non-identical B. burgdorferi in vivo-expressed (Bbive) DNA fragments from across the 
chromosome and all 21 plasmid replicons of the B. burgdorferi B31 segmented genome 
(Table 4). Although the 1:1 molar ratio of insert to vector used to generate the pBbIVET 
library did not preclude insertion of more than one fragment into each clone, only 20 out 
of the 289 clones were found to harbor two distinct DNA fragments. Of these clones the 
3’ DNA fragment, proximal to the pncA ORF, was assumed to be the active promoter 
and was included in the subsequent analyses.   
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 Figure 4: Representative restriction digest analysis of individual pBbIVET 
plasmids rescued in E. coli. 
Colony PCR to amplify the in vivo-expressed DNA fragment was performed on a 
random subset of twenty four E. coli transformants carrying the rescued pBbIVET 
plasmids from infected mouse tissues. The PCR products were digested with a cocktail 
of the restriction enzymes DraI, SspI and AseI and separated on a 1% agarose gel.  
Numbers across the top of each image identify each non-identical restriction digestion 
pattern detected for the amplified pBbIVET DNA fragments. Representative data from 
two mouse tissues (A) and (B) are shown. Migration of the DNA ladders is shown in 
base pairs on both sides of each image. NTC, PCR no template control. 
 
2.2.4: B. burgdorferi In Vivo Expressed Promoters Map To Distinct Classes Of 
Putative Regulatory Sequences Across The Genome. 
Genomic mapping of the 289 unique Bbive promoters identified in this genetic 
screen demonstrated that 67% of the sequences mapped to sense DNA in the same 
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direction as annotated open reading frames, 27% mapped to antisense DNA in the 
opposite direction to annotated open reading frames and 6% mapped to intergenic 
regions lacking annotated open reading frames. Of the large percentage of sense 
sequences, 41%, which represented 28% of the total Bbive sequences, mapped to 
regions just upstream of and in the same orientation to annotated open reading frames, 
suggesting that these sequences are promoters for the associated open reading frames 
and that these open reading frames are candidate in vivo-expressed genes. The 
remaining 59% of the sense sequences, which represented 39% of the total Bbive 
sequences, mapped within annotated open reading frames, suggesting the possibility 
for promoter elements within B. burgdorferi genes. Similar findings of putative 
transcriptional start sites within genes and operons have been reported for other 
bacterial pathogens [130, 131]. The sequences that mapped to putative promoter 
locations in the genome and the genes associated with these promoters were prioritized 
for further analysis. Among the list of 80 sequences, 9 promoter regions were 
represented by two overlapping genomic DNA fragments. Five of these overlapping 
sequence pairs shared the same 3’ end, suggesting that the sequences belonging to 
each pair contained the same promoter. Whereas, the other four overlapping sequence 
pairs harbored distinct 3’ ends, suggesting that each sequence contained a unique 
promoter. The 71 in vivo-expressed candidate genes have been annotated to encode 
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proteins in various functional categories including: cell division, cell envelope, 
replication, metabolism, motility, protein synthesis, transport and unknown functions 
(Table 5).  
2.2.5: IVET Identified Candidate Gene bbk46 On Virulence Plasmid lp36. 
Linear plasmid 36 is required for B. burgdorferi mouse infection; however, the 
genetic elements on lp36 that contribute to this phenotype have not been fully defined 
[16].  IVET identified a candidate in vivo-expressed promoter sequence, Bbive162, 
which mapped to lp36.  This sequence was found to be 60 bp long, with 48 bp 
immediately upstream of and in the same direction as the BBK46 open reading frame 
(Fig. 5), suggesting that the bbk46 gene may be expressed during mammalian infection 
and may contribute to the essential role of lp36 in B. burgdorferi infectivity. Therefore, 
the bbk46 gene was selected for further analysis.  
2.2.6: Expression Of The bbk46 Gene Is Induced During Murine Infection. 
Our BbIVET screen identified gene bbk46 as a putative in vivo-expressed gene.  
The BbIVET screen was designed to identify B. burgdorferi DNA fragments that are 
expressed in vivo and did not discriminate between those promoters that are specifically 
induced in vivo and those promoters that are expressed both in vitro and in vivo.  
Therefore, quantitative reverse transcription PCR (qRT-PCR) was used to validate the 
expression of bbk46 in vivo and to determine whether bbk46 expression was 
upregulated in vivo compared to in vitro. 
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Table 5: B. burgdorferi in vivo expressed candidate genes organized by functional category. 1 
Bbive clonea Replicon ORFb Protein designation, Annotated 
functionc 
Cell division    
289 chromosome BB0715 FtsA cell division protein 
Cell envelope    
15 chromosome BB0213 Putative lipoprotein 
94 chromosome BB0760 Gp37 protein 
175 lp54 BBA36 Lipoprotein 
271 lp54 BBA57 Lipoprotein 
297 lp25 BBE16 BptA 
151 lp28-2 BBG01  Putative lipoprotein 
267 lp38 BBJ34 Putative lipoprotein 
269 lp38 BBJ51 VlsE paralog, pseudogene 
162 lp36 BBK46 Immunogenic protein P37, authentic 
frameshift 
77 cp32-8, cp32-3, cp32-7, 
cp32-9, lp56, cp32-4,cp32-
6, cp32-1 
BBL28, BBS30, BBO28, 
BBN28, BBQ35, BBR28, 
BBM28, BBP28 
Mlp lipoprotein family 
DNA replication    
274 chromosome BB0111 DnaB replicative helicase 
226 chromosome BB0632 RecD exodeoxyribonuclease V, 
alpha chain 
152 lp28-3 BBH13 RepU replication machinery 
Energy metabolism    
62 chromosome BB0057 Gap glyceraldehyde-3-phosphate 
dehydrogenase, type 1 
34 chromosome BB0327 Glycerol-3-phosphate O 
acyltransferase 
44 chromosome BB0368 NAD(P)H-dependent glycerol-3-
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Bbive clonea Replicon ORFb Protein designation, Annotated 
functionc 
phosphate dehydrogenase 
47 chromosome BB0381 Trehalase 
81 chromosome BB0676 Phosphoglycolate phosphate 
    
Fatty acid and 
phospholipid 
metabolism 
   
85 chromosome BB0704 AcpP acyl carrier protein 
Motility and 
chemotaxis 
   
14 chromosome BB0181 FlbF putative flagellar protein 
29 chromosome BB0293 FlgB flagellar basal body rod 
290 chromosome BB0755 Flagellar hook-basal body complex 
protein 
65 chromosome BB0551 CheY-1 chemotaxis response 
regulator 
222 chromosome BB0568 Chemotaxis response regulator 
protein-glutamate methylesterase 
Prophage function    
295 cp32-8, cp32-7, cp32-1, 
cp32-3, cp32-6, cp32-4 
BBL23, BBO23, BBP23, 
BBS23, BBM23, BBR23 
Holin BlyA family 
Protein fate    
193 chromosome BB0031 LepB signal peptidase I 
Protein synthesis    
202 chromosome BB0113 RpsR ribosomal protein S18 
216, 217 chromosome BB0485 RplP ribosomal protein L16 
58 chromosome BB0495 RpsE 30S ribosomal protein S5 
59 chromosome BB0496 50S ribosomal protein L30 
219 chromosome BB0503 RplQ ribosomal protein L17 
232 chromosome BB0660 GTP-binding Era protein 
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Bbive clonea Replicon ORFb Protein designation, Annotated 
functionc 
288 chromosome BB0682 TrmU tRNA (5-methylaminomethyl-
2-thiouridylate)-methyltransferase  
Regulation    
208 chromosome BB0379 Protein kinase C1 inhibitor 
50 chromosome BB0420 Hk1 histidine kinase 
Nucleoside salvage    
148 lp25 BBE07 Pfs protein, pseudogene 
Transcription    
1 chromosome BB0389 RpoB DNA-directed RNA 
polymerase, beta subunit 
287 Chromosome  BB0607 PcrA ATP-dependent DNA helicase 
84 chromosome BB0697 RimM 16S rRNA processing protein 
Transport    
204 chromosome BB0318 MglA methylgalactoside ABC 
transporter ATP-binding protein 
46 chromosome BB0380 MgtE Mg2+ transport protein 
Unknown    
56 chromosome BB0049 Hypothetical protein 
69 chromosome BB0063 Pasta domain protein 
2 chromosome BB0102 Conserved hypothetical 
8 chromosome BB0138 Conserved hypothetical 
13 chromosome BB0176 ATPase family associated with 
various cellular activities 
23 chromosome BB0265 Conserved hypothetical 
212 chromosome BB0428 Conserved hypothetical 
52, 53 chromosome BB0429 Conserved hypothetical 
220 chromosome BB0504 Conserved hypothetical 
67 chromosome BB0562 Conserved hypothetical 
223 chromosome BB0577 Conserved hypothetical 
71 chromosome BB0592 Caax amino protease family 
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Bbive clonea Replicon ORFb Protein designation, Annotated 
functionc 
73 chromosome BB0619 DHH family phosphoesterase 
function 
96 chromosome BB0799 Conserved hypothetical 
240 cp26 BBB27 Unknown essential protein 
145, 146 lp25 BBE0036 Hypothetical protein 
147 lp25 BBE01 Conserved hypothetical 
265, 266 lp38 BBJ30 Conserved hypothetical 
171 lp38 BBJ36 Conserved hypothetical 
173 lp38 BBJ46 Conserved hypothetical 
129, 296 cp32-8, cp32-1, cp32-7, 
lp56, cp32-9 
BBL41, BBP40, BBO42, 
BBQ48, BBN41 
Conserved hypothetical 
130, 151 cp32-8, cp32-1, cp32-6 BBL42, BBP41, BBM41 Conserved hypothetical 
117 cp32-6, lp56, cp32-9, cp32-
8, cp32-3, cp32-1, cp32-4 
BBM18, BBQ25, BBN18, 
BBL18, BBS18,BBP18, 
BBR18 
Conserved hypothetical 
182, 183 lp56 BBQ41 PF-49 protein 
188 lp56 BBQ84.1 Conserved hypothetical 
189 lp56, lp28-3, lp17 BBQ89, BBH01, BBD01 Conserved domain protein 
244 cp32-4, cp32-3, cp32-6, 
lp56, cp32-8, cp32-9 
BBR05, BBN05, BBM05, 
BBQ12, BBL05, BBO05, 
BBP05 
Lyme disease protein of unknown 
function 
157 lp28-4 BBI07 Conserved hypothetical 
aIn some cases two Bbive clones shared overlapping, non-identical sequence, as indicated by two Bbive clone numbers. 2 
bORF, open reading frame that maps just downstream and in the same orientation to the Bbive sequence. 3 
cAnnotation described by Fraser et al. [7]. 4 
  5 
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 Figure 5: The nucleotide and putative amino acid sequence of the BBK46 open 
reading frame. 
The reverse complement of nucleotides 28391 to 29474 on lp36, encompassing bbk46 
(Genbank GeneID: 1194234) and its putative promoter sequence. The nucleotide 
sequence of Bbive162 is underlined. The putative ribosome binding site is shown in 
bold italics. The putative BBK46 amino acid sequence is shown in bold. The stop 
codons at nucleotides 625 and 820 are highlighted in gray. The position of the inserted 
FLAG-epitope tag sequence is indicted with a star (*).The position of the inserted cMyc-
epitope tag sequence is indicated with a number sign (#).  
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Total RNA was isolated from bladder tissue collected from mice infected with 
1x105 wild-type B. burgdorferi three weeks post-inoculation as well as log phase in vitro 
grown spirochetes. RNA was converted to cDNA using random hexamer primers and 
the mRNA level of each target gene was measured relative to the constitutive recA 
gene using quantitative PCR. The gene expression levels of flaB and ospC were also 
measured as control constitutively-expressed and in vivo-induced genes, respectively. 
These data demonstrated that although bbk46 was expressed during in vitro growth, 
expression of this gene was increased more than 100-fold during mammalian infection 
(Fig. 6A). Consistent with their known patterns of gene regulation, flaB expression was 
relatively unchanged in vivo compared to in vitro; whereas, ospC demonstrated a nearly 
1000-fold increase in expression in vivo compared to in vitro (Fig. 6A). Moreover, the 
relative amount of bbk46 expression during in vitro growth was found to be 
approximately 10-fold more than that of ospC. Whereas, the in vivo expression levels of 
genes bbk46, ospC and flaB were similar. 
RpoS is a global regulator that controls expression of genes expressed during 
mammalian infection, including ospC [51]. Because bbk46 expression was induced in 
vivo in a manner similar to that of ospC, we sought to determine whether, like ospC, 
bbk46 is an RpoS-regulated gene. RNA was isolated from stationary phase 
temperature-shifted wild-type and ∆rpoS mutant spirochetes, a growth condition 
previously shown to induce expression of rpoS and rpoS-regulated genes [52].  
Quantitative RT-PCR was then performed for genes bbk46, flaB, ospC and recA, as 
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described above.  As expected, ospC expression was increased approximately 20 times 
in the presence compared to the absence of rpoS (Fig. 6B). In contrast, bbk46 
expression was RpoS-independent under these growth conditions (Fig. 6B). Likewise, 
no RpoS-dependent change in gene expression was detected for flaB. Interestingly, the 
amount of flaB expression detected in the stationary phase temperature-shifted 
spirochetes (Fig. 6B) was dramatically decreased compared to the amount of flaB 
expression detected in log phase and in vivo grown spirochetes (Fig. 6A), suggesting 
that flaB is not expressed at the same level under all growth conditions. Together these 
data demonstrated that bbk46 was highly induced during murine infection and bbk46 
expression was not controlled by RpoS during in vitro growth. 
2.2.7: The bbk46 Open Reading Frame Fails To Produce Detectable Amounts Of 
Protein During In Vitro Growth. 
The bbk46 gene is a member of paralogous gene family 75, which also includes 
lp36-encoded genes bbk45, bbk48 and bbk50, all of which are annotated to encode 
putative P37 immunogenic lipoproteins [7, 8, 132] (Fig. 7). These genes are located on 
the right arm of lp36 in B. burgdorferi clone B31, which is a highly variable region 
among distinct B. burgdorferi isolates [132]. 
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 Figure 6: Expression of the bbk46 gene is upregulated during murine infection 
and is RpoS-independent. 
Total RNA was isolated from bladder tissue collected from (A) mice infected with 1x105 
wild-type B. burgdorferi three weeks post-inoculation (in vivo, gray bars) and from log 
phase in vitro grown spirochetes (in vitro, white bars) or (B) stationary phase 
temperature-shifted stationary phase in vitro grown wild-type (white bars) or ∆rpoS (gray 
bars) B. burgdorferi. RNA was reverse transcribed to cDNA using random hexamer 
primers. The expression of bbk46, flaB and ospC were quantified using quantitative 
reverse transcription polymerase chain reaction (qRT-PCR) and a standard curve 
analysis method. The mRNA levels of the bbk46, flaB and ospC gene transcripts were 
normalized to that of the constitutive recA gene. The data are expressed as the gene 
transcript/recA transcript. The data represent the average of triplicate qRT-PCR 
analyses of 3 biological replicates. Error bars represent the standard deviation from the 
mean.  
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The members of paralogous gene family 75 are conserved within B. burgdorferi 
isolates but are not present in the relapsing fever spirochetes. The B. burgdorferi clone 
B31 BBK45, BBK48 and BBK50 proteins are predicted to be 301, 288 and 332 amino 
acids, respectively. However, B. burgdorferi clone B31 bbk46 is annotated as a 
pseudogene as a result of an authentic frame shift resulting in a TAA stop codon at 
nucleotide 625 [7, 8, 132], thereby producing a putative 209 amino acid protein. In 
contrast, the BBK46 homolog in clone N40, BD04, harbors a CAA codon at nucleotide 
625, resulting in a glutamic acid residue at amino acid 209 and producing a putative 273 
amino acid protein [66]. Sequence analysis of the cloned bbk46 open reading frame 
confirmed the presence of the TAA stop codon at nucleotide 625 (Fig. 5). To 
experimentally determine the size of the BBK46 protein produced in B. burgdorferi B31 
the bbk46 ORF along with a FLAG epitope tag sequence prior to the stop codon at 
nucleotide 625 and a cMyc epitope tag sequence prior to the stop codon at nucleotide 
820 (Fig. 5) was cloned into the B. burgdorferi shuttle vector pBSV2G under the control 
of either the constitutive flaB promoter or the putative endogenous bbk46 promoter.  
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 Figure 7: Amino acid alignment of the putative members of the immunogenic 
protein P37 family encoded on lp36. 
Shown is an amino acid alignment of the P37 protein family members BBK45 (GenBank 
accession no. NP_045617.2), BBK46 (translated bbk46, Genbank GeneID: 1194234), 
BBK48 (GenBank accession no. NP_045619.1) and BBK50 (GenBank accession no. 
NP_045621.1). Amino acids identical to the consensus sequence are shaded. The 
predicted SpLip lipobox sequence [133] is indicted with five stars. Dashes represent 
spaces introduced for optimal sequence alignment. The positions of the two stop 
codons in the bbk46 translation are indicated with arrows. Amino acid sequences were 
aligned using the CLUSTAL W algorithm in the MEGALIGN program from the 
DNASTAR Lasergene suite.   
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A mutant clone lacking the entire BBK46 open reading frame was constructed by 
allelic exchange and verified by PCR analysis (Fig. 8A and 8B). The bbk46 mutant 
clone was transformed with the shuttle vectors carrying the epitope tagged bbk46 
constructs. All transformants were verified to contain the plasmid content of the parent 
clone. BBK46 protein production was assessed in both E. coli and B. burgdorferi.  
Immunoblot analyses using αFLAG and αcMyc monoclonal antibodies resulted in 
detection of a FLAG-epitope tagged protein of an approximate molecular mass of 23 
kDa, which is the predicted size of the 209 amino acid BBK46 protein, in the E. coli 
clones carrying both the flaBp-driven and the bbk46p-driven constructs (Fig. 9).  
Surprisingly, no FLAG epitope tagged protein was detected in either B. burgdorferi 
clone (Fig. 9), although bbk46 gene expression was observed in these clones (data not 
shown), indicating that the lack of detectable BBK46 protein was not likely the result of a 
transcription defect. Furthermore, no cMyc epitope tagged protein was detected in 
either E. coli or B. burgdorferi. Together these data suggested that although the bbk46 
ORF is competent to produce a 23 kDa protein in E. coli and the transcript is expressed 
in B. burgdorferi during in vitro growth, the protein is either not produced or is rapidly 
turned over in log phase in vitro grown B. burgdorferi.  
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 Figure 8: Generation of the ∆bbk46 mutant and genetic complemented clones of 
B. burgdorferi. 
(A) Schematic representation of the wild-type (WT) and ∆bbk46 loci on lp36. The 
sequence of the entire bbk46 open reading frame was replaced with a flaBp-aadA 
antibiotic resistance cassette [16, 134]. Locations of primers for analysis of the mutant 
clones are indicated with small arrows and labels P7-P12, P19 and P20. Primer 
sequences are listed in Table 5. (B) PCR analysis of the ∆bbk46 mutant clone. Genomic 
DNA isolated from WT and ∆bbk46/ vector spirochetes served as the template DNA for 
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PCR analyses. DNA templates are indicated across the bottom of the gel image. The 
primer pairs used to amplify specific DNA sequences are indicated at the top of the gel 
image and correspond to target sequences as shown in (A). Migration of the DNA 
ladder in base pairs is shown to the left of each image. (C) In vitro growth analysis of 
mutant clones. A3-68∆BBE02 (WT), bbk46::flaBp-aadA/ pBSV2G (∆bbk46/ vector) and 
bbk46::flaBp-aadA/ pBSV2G-bbk46 (∆bbk46/ bbk46+) spirochetes were inoculated in 
triplicate at a density of 1x105 spirochetes/ml in 5 ml of BSKII medium. Spirochete 
densities were determined every 24 hours under dark field microscopy using a Petroff-
Hausser chamber over the course of 96 hours. The data are represented as the number 
of spirochetes per ml over time (hours) and is expressed as the average of 3 biological 
replicates. Error bars indicate the standard deviation from the mean. 
 
 
Figure 9: BBK46 protein production is detectable in E. coli but not in B. 
burgdorferi. 
Immunoblot analysis of total protein lysate prepared from 1.5x108 B. burgdorferi ∆bbk46 
(Bb) or E. coli harboring either pBSV2G flaBp-bbk46-FLAG-cMyc (flaBp) or pBSV2G 
bbk46p-bbk46-FLAG-cMyc (bbk46p). Protein lysates were separated by SDS-PAGE and 
immunoblots performed using anti-FLAG monoclonal antibodies (α FLAG) and anti-
cMyc monoclonal antibodies (α cMyc). 300 ng of purified PncA-FLAG [117] and GST-
BmpA-cMyc [135] proteins served as positive controls (+) for each antibody. The 
positions of markers to the left of the panel depict protein standard molecular masses in 
kilodaltons. 
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As a putative member of the P37 immunogenic lipoprotein family, BBK46 is 
predicted to localize to the spirochete outer surface and to be immunogenic during 
mammalian infection.  Therefore, recombinant BBK46, lacking the first 32 amino acids 
that are predicted to comprise the signal sequence for the lipoprotein, was produced in 
E. coli as an N-terminal fusion to glutathione S-transferase (GST). To assess the 
immunogenicity of the BBK46 protein, immunoblot analysis was performed using 
purified rGST-BBK46 probed with mouse immune serum collected 21 days post 
inoculation with 1x104 wild-type B. burgdorferi. The rGST-BBK46 protein was found to 
be non-immunoreactive with mouse immune serum, in contrast to the control antigen 
BmpA (Fig. 10). These data suggest that, if produced in B. burgdorferi, BBK46 is not an 
immunoreactive antigen. However, these data do not rule out the possibility that the 
immunogenic epitope is not present or available in the recombinant protein produced in 
E. coli. 
2.2.8: The bbk46 Gene Is Required For B. burgdorferi Persistence In 
Immunocompetent Mice. 
In vitro growth analysis demonstrated that the bbk46 mutant and complemented 
clones had no detectable in vitro phenotypes (Fig. 8C). Therefore, to examine the role 
of bbk46 in mouse infectivity, groups of five C3H/HeN female mice were needle 
inoculated intradermally under the skin of the upper back with 1x104 wild-type, 
∆bbk46/vector or ∆bbk46/bbk46+ spirochetes. 
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 Figure 10: The BBK46 protein is non-immunogenic in mice. 
Recombinant GST-BBK46 and GST alone produced in and purified from E. coli, along 
with total protein lysate from E. coli and B. burgdorferi (Bb lysate) and E. coli producing 
the B. burgdorferi antigen BmpA (+) were separated by SDS-PAGE and transferred to a 
nitrocellulose membrane. Immunoblot analysis was performed using immune serum 
collected from mice infected with wild-type B. burgdorferi and anti-GST monoclonal 
antibodies (α GST). The positions of markers to the left of the panel depict protein 
standard molecular masses in kilodaltons. 
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Three weeks post inoculation, mice were assessed for B. burgdorferi infection by 
serology and reisolation of spirochetes from the inoculation site, ear, bladder and joint 
tissues. All five mice from each infection group were seropositive for anti-B. burgdorferi 
antibodies (Fig. 11, Table 6). Surprisingly however, no spirochetes were reisolated from 
all tissues examined from the five mice inoculated with the ∆bbk46/vector clone (Table 
6), whereas, all five mice inoculated with the wild-type or the ∆bbk46/bbk46+ clone 
resulted in reisolation of spirochetes from all tissues analyzed (Table 6). Together these 
data demonstrated that spirochetes lacking the bbk46 gene transiently infected and 
elicited a humoral response in mice, but were unable to maintain a persistent infection 
in mouse tissues. To further define the contribution of the host immune response to the 
inability of spirochetes lacking the bbk46 genes to cause a persistent infection, groups 
of five severe combined immunodeficiency (scid) mice were inoculated with 1x104 wild-
type, ∆bbk46/vector or ∆bbk46/bbk46+ spirochetes. Three weeks post inoculation the 
animals were assessed for infection by reisolation of spirochetes from the ear, bladder 
and joint tissues.  Consistent with the hypothesized role of bbk46 in immune evasion 
and persistence, four out of five immunodeficient mice inoculated with the ∆bbk46 
mutant were positive for spirochete reisolation from all tissues examined (Table 6). 
These data demonstrated that a functional host immune response is required for the 
clearance of spirochetes lacking bbk46 from mouse tissues 3 weeks post infection, 
indicating that bbk46 is essential for the ability of B. burgdorferi to avoid killing by the 
host immune system in order to establish a persistent infection.  
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 Figure 11: Spirochetes lacking bbk46 retain seroreactivity in mice. 
Immunoblot analysis of sera collected three weeks post inoculation from groups of five 
C3H/HeN mice inoculated with clone A3-68∆BBE02 (WT), bbk46::flaBp-aadA/ pBSV2G 
(∆bbk46/ vector) and bbk46::flaBp-aadA/ pBSV2G-bbk46 (∆bbk46/ bbk46+) at a dose of 
1x104 spirochetes  per mouse. (A) Total protein lysate from B. burgdorferi clone B31 A3 
was probed with the serum from each individual mouse (1-5). (B) Purified recombinant 
GST-OspC protein was probed with pooled sera from the five mice in each infection 
group or αOspC polyclonal antibodies. The positions of markers to the left of the panel 
depict protein standard molecular masses in kilodaltons.  
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Table 6: The bbk46 gene is required for persistent infection of immunocompetent 
mice. 
Clone Serologya Positive reisolation of spirochetes from 
mouse tissuesb 
  Inoculation site Ear Bladder Joint 
Immunocompetent mice      
wild-type 5/5 5/5 5/5 5/5 5/5 
∆bbk46/vector 5/5 0/5 0/5 0/5 0/5 
∆bbk46/bbk46+ 5/5 5/5 5/5 5/5 5/5 
Immunodeficient mice      
wild-type NA NA 5/5 5/5 5/5 
∆bbk46/vector NA NA 4/5 4/5 4/5 
∆bbk46/bbk46+ NA NA 5/5 5/5 5/5 
aDetermined 3 weeks post inoculation by serological response to B. burgdorferi total 
protein lysate and recombinant OspC protein. NA, not applicable. 
bNumber of mice positive for spirochete reisolation/ number of mice analyzed. NA, not 
applicable. 
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2.3: Discussion 
In this study we have successfully adapted and applied for the first time an IVET-
based genetic screen for use in B. burgdorferi for the purpose of identifying spirochete 
genes that are expressed during mammalian infection. Historically, genetic manipulation 
of low passage, infectious B. burgdorferi has been challenged by the low transformation 
frequencies of these spirochetes, preventing application of classic in vivo genetic 
screening techniques such as in vivo expression technology (IVET) and signature-
tagged mutagenesis (STM) [136] to identify B. burgdorferi genetic elements important 
for pathogenicity. However, advances in the understanding of the B. burgdorferi 
restriction modification systems that inhibit transformation [124, 137-140] have recently 
allowed construction and characterization of a comprehensive STM mutant library in 
infectious B. burgdorferi [26]. The foundation for our strategy for development of IVET in 
B. burgdorferi was based upon the spirochete’s requirement of lp25 for both restriction 
modification and virulence functions. Spirochetes lacking lp25 are highly transformable 
but non-infectious in mice [13, 14, 18, 124]. Restoration of the lp25-encoded pncA gene 
to lp25- spirochetes restores wild-type infectivity [12] but maintains high transformation 
frequency. At the time of the development of the pBbIVET system the true start codon 
of the pncA gene was not defined; therefore, the promoter-less pncA gene construct in 
the pBbIVET plasmid used an engineered AUG start codon and was missing the first 24 
nucleotides of the now defined pncA ORF [117]. Furthermore, this construct was 
purposefully designed without a ribosome binding site (RBS) and was dependent upon 
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the cloned B. burgdorferi DNA fragments to contain both a promoter and a functional 
RBS. Although we acknowledge that this requirement may have limited the number of 
clones identified in our screen, during development of the BbIVET system we found that 
inclusion of an RBS sequence in the promoterless pncA construct resulted in vector-
driven PncA production in the absence of a promoter. Thus, in order to reduce the 
possibility of recovering false positive clones, the pBbIVET system was designed 
without an RBS. The enzyme Tsp509I was selected to generate the DNA fragments for 
the pBbIVET library because the AATT restriction site of this enzyme is present 
approximately every 58 bp in the B. burgdorferi B31 genome. However, it is possible 
that DNA fragments generated with this enzyme will not result in sequences that contain 
a 3’ RBS appropriately distanced from the start codon of the pncA ORF, thereby limiting 
the number of clones identified in the screen.   
Screening of a 15,000 clone B. burgdorferi genomic library in mice identified 289 
DNA sequences from across all 22 B. burgdorferi replicons capable of promoting pncA 
expression resulting in an infectious phenotype. It is likely that the BbIVET screen did 
not achieve saturation because the number of clones analyzed was only estimated to 
cover the B. burgdorferi genome one time, under the assumption that each cloned DNA 
fragment in the library was unique. Analysis of the pBbIVET library in B. burgdorferi 
suggested that the library was composed of 15,000 unique clones. However, because 
only a small fraction of the library was examined for the sequences of the DNA fragment 
inserts, our findings do not rule out the potential that the library was composed of less 
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than 15,000 non-identical clones and therefore, may represent less than 1X coverage of 
the genome. Of the 175 mice infected with the pBbIVET library, 10% resulted in 
reisolation of a single clone, 62% resulted in reisolation of two to five unique clones, and 
28% resulted in reisolation of six to eleven unique clones. Furthermore, 57% of the 289 
Bbive sequences were only recovered once; whereas, 39% of the sequences were 
recovered two to five times and 4% of the sequences were recovered six to twelve 
times. These data are indicative of the amount of redundancy in the screen and suggest 
that although the screen may not have been representative of the entire B. burgdorferi 
genome, a large percentage of mice became infected with multiple clones and many of 
the Bbive sequences were recovered more than once.   
We found that 71 of the Bbive sequences mapped to canonical promoter 
positions upstream of annotated open reading frames in the B. burgdorferi genome.  
Unexpectedly, the well characterized in vivo-expressed ospC promoter was not among 
these sequences. However, the ospCp was successfully recovered in our functional 
validation of the BbIVET system, suggesting that the BbIVET screen had not reached 
complete saturation of the genome and with further screening of the BbIVET library the 
ospCp sequence may be recovered. Alternatively, given that ospC expression is known 
to be down-regulated after the initial stages of infection [42, 43, 141-143] it is possible 
that in the context of a mixed infection individual pBbIVET clones carrying the ospCp 
lack a fitness advantage due to decreased expression three weeks post inoculation and 
may not be recovered in our screen. This explanation may appear to conflict with the 
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findings reported herein that ospC expression is high at three weeks post inoculation 
and the ospCp served as a robust positive control promoter for the BbIVET system.  
However, down-regulation of ospC expression at this time point in infection is a 
stochastic process that occurs at the level of the individual spirochete and does not 
occur simultaneously across the entire population [142]. Although at the population level 
the ospCp is expressed at this time point in our studies, in the context of the BbIVET 
screen individual clones carrying the ospCp may express reduced amount of pncA and 
may be out competed by other BbIVET clones carrying stronger promoters.   
A subset of the genes identified in the BbIVET screen included known in vivo-
expressed genes, which provided validation that our genetic system was working as 
expected and was sufficiently powerful. The screen recovered the promoter for genes 
bba36 (Bbive175), bba57 (Bbive271), bbb27 (Bbive240), bbj34 (Bbive267), bbj36 
(Bbive171), bbj51 (Bbive269), bb0213 (Bbive15) and bb0760 (Bbive94), all of which 
have been shown previously to be expressed during mammalian infection [42].  
Furthermore, bba57 was recently reported to be up-regulated in vivo and to contribute 
to pathogenesis in the mouse [144]. The bptA gene encodes a function that has been 
shown to be required for B. burgdorferi survival in the tick and to contribute to mouse 
infectivity [120, 121]. In addition, Bbive14, 58, 232, 84, 269, 295 and 77 are associated 
with genes that have been shown to be up-regulated in in vivo-like conditions and/or 
gene products that are immunogenic in humans and mice [76, 100, 145, 146]. Notably, 
few in vivo-expressed candidate genes identified using BbIVET were previously 
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observed to be up-regulated in mammalian host-adapted spirochetes derived from 
growth within rat dialysis membrane chambers (DMCs). Genes identified in our 
analyses that have also been detected by microarray analysis of DMC grown 
spirochetes include bba36 [76, 103], bbj51 [76, 102], bb0551, bbm28 [76], bb0495, and 
bb0660 [102]. The results of the DMC microarray studies are reported as genes that are 
significantly up-regulated in DMC-derived spirochetes relative to spirochetes grown in 
vitro; whereas, the BbIVET screen does not distinguish between genes that are 
specifically induced in vivo and genes that are expressed both in vitro and in vivo.  
Furthermore, the environmental cues within the DMCs may not fully reflect those 
experienced by B. burgdorferi during an active infection. Finally, the BbIVET system 
specifically selects for promoters that are capable of driving expression of pncA allowing 
the spirochetes to survive throughout a three week mouse infection. Together, these 
technical and biological differences between the DMC microarray and BbIVET screen 
likely contributed to the distinct results obtained from the two methods of gene 
expression analysis. In addition, few genes that have been previously established to be 
RpoS-regulated in vitro and/or within DMCs [58, 103] were identified by the BbIVET 
screen. RpoS-regulated genes bba36, bba57, bb0265 and bbh01 [58, 103] were among 
the in vivo-expressed Bbive candidate genes. Similarly, only one putative BosR-
regulated gene, bb0592 [61], was identified in the BbIVET screen. Although it is unclear 
why only a small number of know RpoS-regulated promoters were recovered, the 
recently identified AT-rich BosR binding site [61] contains the restriction site for the 
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Tsp509I restriction enzyme used to generate the BbIVET library. Therefore, it is 
possible that the BosR binding sites were subject to cleavage by Tsp509I, perhaps 
resulting in a limited number of DNA fragments that contained BosR-dependent 
promoters.   
The BbIVET screen was carried out in such a way that both DNA fragments that 
are expressed in vitro and in vivo, as well as those fragments that are specifically 
induced in vivo, could be recovered. Therefore, it was not surprising that genes 
encoding cell division, DNA replication, energy metabolism, protein synthesis and 
transcription functions were identified, all of which are likely functions essential for 
spirochete growth under all condition. These findings were consistent with those 
categories of genes not recovered by genome-wide transposon mutagenesis, 
suggesting that these genes encode essential functions [26]. The BbIVET screen 
identified genes that encode proteins in functional categories that may contribute to B. 
burgdorferi infectivity and pathogenesis including, putative lipoproteins, motility and 
chemotaxis proteins, transport proteins and proteins of unknown function. Similarly, 
transposon mutagenesis analysis indicated that motility and chemotaxis genes as well 
as transport genes are important for B. burgdorferi survival in the mouse [26]. 
Linear plasmid 36 is known to be critical for B. burgdorferi survival in the mouse; 
however, the genes on lp36 that contribute to this requirement have not been fully 
characterized [16]. The recently published comprehensive STM study suggests that 
many of the genes encoded on lp36 participate in B. burgdorferi infectivity [16, 26].  
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BbIVET identified gene bbk46 on lp36. We found that bbk46 was expressed both in vitro 
and in vivo. However, bbk46 expression was dramatically induced in spirochetes 
isolated from infected mouse tissues as compared to spirochetes grown in vitro, 
suggesting a possible role for this gene in B. burgdorferi infectivity. Moreover, consistent 
with lack of identification of bbk46 as an RpoS-regulated genes in previous studies of 
the RpoS regulon [103, 147],control of bbk46 expression was found to be RpoS-
independent under in vitro growth conditions that typically induce expression of rpoS 
regulated genes [52, 58, 76, 99]. These findings highlight the power and uniqueness of 
the IVET-based approach for identification of B. burgdorferi in vivo-expressed genes, 
which might not be discovered using other genome-wide gene expression methods. 
Surprisingly, BBK46 protein was not detected in spirochetes expressing FLAG epitope 
tagged bbk46 under the control of the putative native promoter or the constitutive flaB 
promoter. Moreover, sera from B. burgdorferi infected mice were non-immunoreactive 
against recombinant BBK46 protein. In support of these data, no peptide corresponding 
to BBK46 has been detected in genome-wide proteome analysis of B. burgdorferi under 
different environmental conditions [148]. Our findings suggest that despite high gene 
expression, the encoded BBK46 protein is produced at low levels in the spirochete 
and/or BBK46 is rapidly turned over in the cell. Alternatively, bbk46 may function as an 
RNA. The molecular nature of the functional product of bbk46 is currently under 
investigation. 
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Deletion of bbk46 from low-passage, infectious B. burgdorferi resulted in no 
observable in vitro growth defect. Immunocompetent mice needle inoculated with 
spirochetes lacking bbk46 were found to be seropositive for B. burgdorferi antibodies 
three weeks post-infection, although the serological responses appeared to be slightly 
diminished relative to those of mice infected with the wild-type and complemented 
clones. Surprisingly, however, no live spirochetes were reisolated from all tissues 
examined from the mutant infected mice at this same time point. Conversely, all mice 
infected with the wild-type or complemented clone were both seropositive and 
reisolation positive. Furthermore, bbk46 was not required for spirochete survival in 
immunocompromised mice. These data indicate that bbk46 is dispensable for the initial 
stages of B. burgdorferi murine infection but this gene is essential for B. burgdorferi 
persistence in mouse tissues and may contribute to a mechanism of spirochete evasion 
of host-acquired immune defenses. 
B. burgdorferi survival in the mammalian host requires diverse mechanisms that 
allow the spirochete to resist and evade the host’s immune responses. However, the 
genetic components of these important properties of the pathogen have yet to be well 
defined. Here we demonstrate that spirochetes lacking bbk46 establish an initial 
infection and are seroreactive but are unable to persist in murine tissues following host 
antibody production. To our knowledge a similar phenotype has been documented for 
only two other B. burgdorferi genes, the lp28-1 encoded vls antigenic variation locus 
[14, 18, 86, 90, 91] and the chromosomally encoded lmp-1(bb0210) gene [89].  
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Moreover, analogous to the bbk46 mutant, the phenotypes of spirochetes lacking a 
functional vls locus as well as spirochetes lacking lmp-1 have been shown to be 
dependent on the host immune response as these mutants demonstrate wild-type 
survival under immune privileged growth conditions and in immunocompromised mice 
[14, 18, 89-91]. Although it is clear that the antigenic switching mechanism conferred by 
the vls locus is essential for B. burgdorferi persistence in the host [90, 91], the precise 
mechanism of vls-dependent immune evasion remains unknown. Similarly the 
mechanism of lmp-1-dependent protection of B. burgdorferi against the host’s humoral 
immune response is unknown [89]. VlsE and Lmp-1 are highly antigenic proteins 
present on the outer surface of the spirochete [85, 89, 149]. The BBK46 open reading 
frame appears to encode a lipoprotein with a predicted signal sequence for outer 
surface localization; however, recombinant BBK46 protein produced in E. coli was not 
found to be seroreactive when analyzed by immunoblot using immune sera collected 
from mice infected with wild-type B. burgdorferi. Future studies are focused on 
elucidation of the role of bbk46 in the pathogenesis of B. burgdorferi. 
In conclusion, we have developed and applied the IVET technology to B. 
burgdorferi to identify spirochete genes expressed during mammalian infection. This 
represents the first use of this system in B. burgdorferi. The power of this system was 
validated by identification of a subset of genes that have been demonstrated previously 
to be upregulated in vivo. Furthermore, IVET identified bbk46, a novel, uncharacterized 
gene located on essential virulence plasmid lp36. We have presented evidence that 
57 
 
bbk46 is highly upregulated during B. burgdorferi murine infection and is critical for the 
spirochete’s ability to persistently infect immunocompetent mouse tissues. Further 
analysis of the molecular mechanism of bbk46-promoted survival, as well as 
identification and characterization of other putative virulence factors identified by 
BbIVET, will contribute to advancing understanding of in vivo persistence and 
pathogenicity of B. burgdorferi. 
2.4: Materials and Methods  
2.4.1: Ethics Statement. 
The University of Central Florida is accredited by the International Association for 
Assessment and Accreditation of Laboratory Animal Care. Protocols for all animal 
experiments were prepared according to the guidelines of the National Institutes of 
Health and were reviewed and approved by the University of Central Florida Institutional 
Animal Care and Use Committee (Protocol numbers 09-38 and 12-42). 
2.4.2: Bacteria Clones And Growth Conditions. 
All B. burgdorferi clones used were derived from clone B31 A3.  Clone A3 68-1, 
which lacks lp25 and lp56 [125] was used for the pBbIVET library. The B31 A3 wild-type 
and rpoS::kan B. burgdorferi clones [150] were used for gene expression experiments. 
All low-passage B. burgdorferi mutant and complemented clones generated herein were 
derived from infectious clone A3-68∆BBE02, which lacks cp9, lp56 and gene bbe02 on 
lp25 [140]. B. burgdorferi was grown in liquid Barbour-Stoenner-Kelly (BSK) II medium 
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supplemented with gelatin and 6% rabbit serum [151] and plated in solid BSK medium 
as previously described [152, 153]. All spirochete cultures were grown at 35oC 
supplemented with 2.5% CO2.  Kanamycin was used at 200 μg/ml, streptomycin was 
used at 50 μg/ml and gentamicin was used at 40 μg/ml, when appropriate. All cloning 
steps were carried out using DH5α E. coli, which were grown in LB broth or on LB agar 
plates containing 50 μg/ml kanamycin, 300 μg/ml spectinomycin or 10 μg/ml gentamicin.  
2.4.3: Generation of the pBbIVET Plasmid. 
The promoterless pncA gene was amplified from B. burgdorferi B31 genomic 
DNA using primers 1 and 2 (Table 7) and Taq DNA polymerase (New England Biolabs).  
The EcoRI/XbaI-digested pncA fragment was cloned into EcoRI/XbaI-linearized plasmid 
pBSV2*TT [117], creating plasmid pBbIVET.  The in vivo-expressed ospC promoter with 
EcoRI ends was amplified from B. burgdorferi B31 genomic DNA using primers 3 and 4 
(Table 7) and cloned into the EcoRI-cut, Antarctic phosphatase-treated (New England 
Biolabs) pBbIVET plasmid in front of the promoterless pncA gene, resulting in plasmid 
pBbIVET ospCp.  All plasmids were analyzed and verified by restriction digest and 
sequence analysis. The pBbIVET and pBbIVET ospCp plasmids were each transformed 
by electroporation into A3 68-1 [125] as described [16] and transformants selected in 
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 solid BSK medium containing kanamycin and confirmed by PCR using primers 1 and 2 
(Table 7).  Total genomic DNA was prepared from PCR-positive clones and screened 
for the presence of the B. burgdorferi plasmid content [150]. The clones that retained 
the plasmid content of the parent clone were used in further experiments. 
2.4.4: Generation Of The pBbivet Library. 
Total genomic DNA was isolated from a 250 ml culture of B. burgdorferi B31 
clone A3 grown to a density 1x108 spirochetes/ml using the Qiagen genomic DNA buffer 
set and Genomic-tip 500/G, according to the manufacturer’s protocol (Qiagen). A3 
genomic DNA was partially digested with Tsp509I (New England Biolabs). The partial 
digests were electrophoretically separated on a 0.8% agarose gel. The 300 to 500 bp 
range of DNA fragments extracted and ligated in a 1:1 molar ratio with EcoRI-digested 
and Antarctic phosphatase-treated pBbIVET. Library ligations were electroporated into 
E. coli Top10 cells (Life Technologies) and transformants selected on LB agar 
containing 50 μg/ml kanamycin, resulting in approximately 30,000 independent clones.  
Plasmid DNA was isolated from these cells and 20 μg aliquots of the plasmid library 
were transformed by electroporation into B. burgdorferi A3 68-1, as previously 
described [153]. One fifth of each transformation was plated on solid BSK medium 
containing kanamycin. B. burgdorferi pBbIVET colonies were verified to contain B. 
burgdorferi DNA fragments by PCR using primers 5 and 6 (Table 7) and the number of 
transformants recovered quantitated. The approximately 15,000 B. burgdorferi clones 
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recovered over 40 transformations were stored in aliquots of pools of approximately 100 
BbIVET clones each in 25% glycerol at -80°C. 
2.4.5: Selection Of B. burgdorferi Clones Having In Vivo Expressed DNA 
Fragments. 
Each BbIVET pool (~100 clones) was grown in 10 ml of fresh BSKII medium to a 
density of 1x108 spirochetes/ml.  In groups of approximately 20 animals, 144 6-8 week 
old C3H/HeN female mice were each inoculated (80% intraperitoneal and 20% 
subcutaneous) with a dose 1x106 spirochetes of a unique pool of ~100 BbIVET clones, 
under the assumption that each clone was present at dose 1x104 spirochetes.  A 
fraction of each inoculum was plated on solid BSK medium and colonies screened for 
the presence of virulence plasmid lp28-1. Three weeks post inoculation, spirochetes 
were reisolated from ear, heart, bladder and joint tissues in 10 ml BSKII medium 
containing 20 μg/ml phosphomycin (Sigma), 50 μg/ml rifampicin (Sigma) and 2.5 mg/ml 
amphotericin B (Sigma) in 0.2% dimethyl sulfoxide (Sigma).  Total genomic DNA was 
isolated from each spirochete cultures using the Wizard genomic DNA purification kit 
(Promega) and transformed into chemically competent E. coli DH5α cells and colonies 
selected on LB agar containing kanamycin to recover the pBbIVET plasmids.  Twenty 
four transformants were chosen at random from each plasmid rescue and colony PCR 
performed using primers 5 and 6 (Table 7) to amplify the in vivo-expressed DNA 
fragment.  PCR products were subsequently digested with a cocktail of restriction 
enzymes (DraI, SspI and AseI) and visualized on a 1% agarose gel.  Approximately 
14,000 E. coli clones were analyzed in this manner.  All unique BbIVET fragments, as 
61 
 
determined by the restriction digest pattern (Fig. 4), were analyzed by direct sequencing 
of the PCR product using primer 5 (Table 7).  Each individual sequence was identified 
by blastn analysis and mapped to its location in the B. burgdorferi B31 genome. 
 2.4.6 Deletion of bbk46. 
We used a PCR-based overlap extension strategy to delete the bbk46 gene. A 
spectinomycin/ streptomycin resistance cassette, flaBp-aadA [154] with blunt ends, was 
amplified from genomic DNA isolated from clone ∆guaAB [125] using Phusion High-
fidelity DNA polymerase (Thermo Scientific) and primers 11 and 12 (Table 7).  The 500 
bp flanking region upstream of the bbk46 ORF was amplified from the B. burgdorferi 
B31 clone A3 genomic DNA using the Phusion High-fidelity DNA polymerase and 
primers 7 and 8 (Table 7). This introduced a 25 bp sequence at the 3’ end of this 
fragment that was complementary to the 5’ end of the flaBp-aadA cassette. Similarly, 
the 500 bp flanking region downstream of the bbk46 ORF was amplified using the 
primers 9 and 10 (Table 7), which introduced a 5’ sequence of 30 bp that was 
complementary to the 3’ end of the resistance cassette.  The PCR products from the 
above 3 reactions were mixed in equal volumes and used as a template for a fourth 
amplification reaction using Phusion High-fidelity DNA polymerase and primers 7 and 
10 (Table 7) in order to generate a product containing the resistance cassette flanked 
by the 500 bp sequences upstream and downstream of the bbk46 ORF. This product 
was ligated with linear pCR-Blunt using a Zero Blunt PCR cloning Kit (Life 
technologies), yielding the allelic exchange plasmid pCR-Blunt-∆bbk46-flaBp-aadA. B. 
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burgdorferi A3-68∆BBE02 was transformed with 20 μg of pCR-Blunt-∆bbk46-flaBp-aadA 
purified from E. coli as previously described [16]. Streptomycin-resistant colonies were 
confirmed to be true transformants by PCR using primer pairs 7 and 10 and 11 and 12 
(Table 7). Positive ∆bbk46-flaBp-aadA clones were screened with a panel of primers 
[150] for the presence of all of the B. burgdorferi plasmids of the parent A3-68∆BBE02 
clone [140], and a single clone was selected for further experiments. 
2.4.7: Complementation Of ∆bbk46 Mutant. 
A PCR-based overlap extension strategy was used to create a DNA fragment 
encompassing the bbk46 gene and putative upstream promoter sequence with the 
introduction of a FLAG epitope tag immediately upstream of the putative premature stop 
codon and a cMyc epitope tag immediately upstream of the downstream stop codon. 
This was done by using Phusion High-fidelity DNA polymerase (New England Biolabs) 
and the primers pairs 13 and 14, 15 and 16, and 17 and 18 (Table 7). A KpnI restriction 
site was introduced at the 5’ end of this fragment and a SalI site at the 3’ end. The 
KpnI+SalI-digested PCR product was ligated into KpnI+ SalI-digested B. burgdorferi 
shuttle vector pBSV2G [155] and cloned in E. coli. The pBSV2G bbk46p-bbk46-FLAG-
cMyc plasmid structure and sequence were confirmed by restriction digest and DNA 
sequence analysis. In addition, a 400 bp DNA fragment encompassing the flaB 
promoter with KpnI and BamHI ends was amplified from B31 A3 genomic DNA using 
primers 27 and 28 (Table 7).  The KpnI+BamHI-digested PCR product was ligated into 
KpnI+ BamHI-digested B. burgdorferi shuttle vector pBSV2G [155].  The bbk46-FLAG-
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cMyc gene without the putative bk46 promoter sequence and with BamHI and SalI ends 
was amplified from pBSV2G bbk46p-bbk46-FLAG-cMyc plasmid DNA using Phusion 
High-fidelity DNA polymerase (New England Biolabs) and primers 29 and 18 (Table 7).  
The BamHI+SalI-digested PCR product was ligated into BamHI+SalI-digested 
pBSV2GflaBp and cloned in E. coli.  The pBSV2G flaBp-bbk46-FLAG-cMyc plasmid 
structure and sequence were confirmed by restriction digest and DNA sequence 
analysis.  The ∆bbk46 mutant was transformed with 20 μg of pBSV2G bbk46p-bbk46-
FLAG-cMyc, pBSV2G flaBp-bbk46-FLAG-cMyc or pBSV2G alone isolated from E. coli 
and positive transformants selected as previously described [16, 74]. The clones that 
retained the B. burgdorferi plasmid content of the parent clone were selected for use in 
further experiments. 
2.4.8: Immunoblot Analysis of BBK46-FLAG-cMyc. 
Production of the BBK46-FLAG-cMyc protein was examined in both E. coli and 
B. burgdorferi carrying pBSV2G bbk46p-bbk46-FLAG-cMyc or pBSV2G flaBp-bbk46-
FLAG-cMyc.  Total E. coli protein lysates were prepared from 2x109 cells harvested 
following overnight growth in LB medium at 37°C with aeration.  E. coli cells were 
resuspended and lysed in 200 μl B-PER protein extraction reagent (Pierce), followed by 
the addition of 200 µl 2x Laemmli sample buffer plus 2-mercaptoethanol (Bio-rad).  Total 
B. burgdorferi protein lysates were prepared from 2x109 spirochetes harvested at mid-
log phase.  The spirochetes were washed twice in 1 ml cold HN buffer (50 mM Hepes, 
50 mM NaCl, pH 7.4) and lysed in 200 μl B-PER protein extraction reagent (Thermo 
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Scientific), followed by the addition of 200 μl 2x Laemmli sample buffer plus 2-
mercaptoethanol (Bio-rad). 30 ml of each protein lysate (~1.5x108 cells) were separated 
by SDS-PAGE and transferred to a nitrocellulose membrane.  300 ng of PncA-FLAG 
[117] and GST-BmpA-cMyc [135] proteins served as positive controls.  Immunoblot 
analysis was performed using anti-FLAG monoclonal primary antibody (Genscript) 
diluted 1:500 in Tris-buffered saline, pH 7.4 and 0.5% Tween20 (TBST) and goat anti-
mouse IgG+IgM-HRP secondary antibody (EMD Millipore) diluted 1:10,000 in TBST and 
the signal detected using SuperSignal West Pico chemluminescent substrate kit 
(Thermo Scientific).  The membrane was then stripped using 0.2M NaOH, reblocked 
using 5% skim milk in TBST and probed with anti-cMyc primary antibody (Genscript) 
diluted 1:500 in TBST and goat anti-mouse IgG+IgM-HRP (EMD Millipore) and 
visualized as described above. 
2.4.9: Cloning, Purification and Seroreactivity Analysis of rGST-BBK46. 
An in-frame glutathinone S-transferase (GST)-BBK46 fusion protein lacking the 
putative BBK46 signal sequence was generated using primers 30 and 31 (Table 5) and 
purified, as previously described [135]. Approximately 1 μg of GST-BBK46 was 
separated by SDS-PAGE, transferred to a nitrocellulose membrane and analyzed by 
immunoblot for seroreactivity using immune serum collected 3 weeks post inoculation 
from mice infected with wild-type B. burgdorferi as previously described [135].  Controls 
included 1 μg of GST alone and total protein lysates generated from BL21 E. coli, B. 
burgdorferi B31 A3 and E. coli expressing B. burgdorferi bmpA [16] prepared as 
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described above.  The membrane was stripped as described above and reprobed with 
anti-GST primary monoclonal antibody (EMD Millipore) diluted 1:1000 in TBST and goat 
anti-mouse IgG+IgM-HRP (EMD Millipore) and visualized as described above. 
2.4.10: In vitro growth analysis.  
Wild-type (A3-68∆BBE02), Δbbk46/vector and Δbbk46/bbk46+ spirochetes were 
inoculated in triplicate at a density of 1x105 spirochetes/ml in 5 ml of BSK II medium. 
Spirochete densities were determined every 24 hours under dark field microscopy using 
a Petroff-Hausser chamber over the course of 96 hours. 
2.4.11: RNA Isolation From In Vitro Grown Spirochetes. 
To obtain in vitro grown log phase spirochetes, wild-type (B31 A3) spirochetes 
were grown in triplicate in 5 ml of BSKII medium pH 7.5 at 35°C to a density of 3x107 
spirochetes/ml.  To obtain stationary phase, temperature-shifted spirochetes, wild-type 
(B31 A3) spirochetes were grown in triplicate in 5 ml of BSKII medium pH 7.5 at 35°C to 
a density of 3x107 spirochetes/ml, transferred to 25°C for 48 hours and then returned to 
35°C for an additional 24-36 hours to a density of 2x108 spirochetes/ml.  A total of 1x107 
spirochetes were harvested from each culture and total RNA was isolated using TRIzol 
reagent (Life Technologies) according to the manufacturer’s instructions. RNA was 
resuspended in 100μl DEPC-treated dH2O. RNA was treated with TURBO DNA-free 
(Life Technologies) to remove any contaminating genomic DNA. 1 μl of Riboguard 
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 (40U/μl) RNAse inhibitor (Epicentre) was added to all samples and RNA stored at -
80°C. 
2.4.12: RNA Isolation From Infected Mouse Tissue. 
B. burgdorferi-infected mouse bladders (see mouse infection experiments below) 
were manually macerated on ice using sterile scalpels and transferred to a 2 ml sterile 
tube containing lysing Matrix D (MP Biomedicals). 1ml of RNA pro solution (FastRNA 
Pro Green kit, MP Biomedicals) was added to each sample on ice. Tissues were 
homogenized using a PowerGen High-Throughput Homogenizer (Fisher Scientific) 
following six cycles of beating for 45 sec and 2 minute incubations on ice. Samples 
were centrifuged at 13,000 rpm for 5 minutes at 4°C. The upper aqueous phase was 
transferred to new tubes and incubated for 5 minutes at room temperature. 500 μl of 1-
bromo-3-chloropropane (Sigma Aldrich) and 45 μl of 5M sodium acetate were added to 
each sample and samples were incubated for an additional 5 minutes at room 
temperature. Samples were centrifuged at 13,000 rpm for 5 minutes at 4°C. The upper 
aqueous phase was transferred to new tubes and RNA precipitated with the addition of 
500 μl of absolute ethanol and 1 μl GlycoBlue (Life technologies). RNA was pelleted by 
centrifugation at 13,000 rpm for 10 minutes at 4°C. RNA was washed with 70% ethanol 
in DEPC-treated dH20 and resuspended in 100 μl DEPC-treated dH20. RNA was treated 
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 with TURBO DNA-free (Life Technologies) to remove any contaminating genomic DNA. 
1 μl Riboguard (40U/μl) RNAse inhibitor (Epicentre) was added to all samples and RNA 
stored at -80°C. 
2.4.13: Gene Expression Analysis. 
cDNA was synthesized from 1.0 μg of each RNA sample using the iScript cDNA 
synthesis kit (Bio-Rad) with random primers according to the manufacturer’s 
instructions. Parallel cDNA reactions were carried out in the absence of reverse 
transcriptase. Real-time quantitative PCR (qPCR) reactions were prepared using 1 μg 
of each cDNA and iQ SYBR Green Supermix (Bio-Rad). Using an Applied Biosystems 
7500 instrument, samples were assayed for the flaB, recA, ospC and bbk46 transcripts 
using primers pairs 21 and 22, 23 and 24, 25 and 26, and 19 and 20, respectively 
(Table 5). Standard curves were generated for each gene target using 100 ng, 10 ng, 
1.0 ng, 0.1 ng, and 0.01 ng of B31 A3 B. burgdorferi genomic DNA and the amount of 
each gene transcript calculated. The recA transcript was used as the endogenous 
reference to which the transcripts of the other genes were normalized. The bbk46 
primers were confirmed to be specific for their gene target. Three biological replicate 
samples were analyzed in triplicate and normalized to recA mRNA. The data were 
reported as the average gene transcript/recA transcript for each sample. The 
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amplification of samples lacking reverse transcriptase was similar to that of the no-
template control. 
2.4.14: Mouse Infection Experiments. 
Unless otherwise noted, groups of 6-8 week old C3H/HeN female mice (Harlan) 
were used for all experiments. 
2.4.14.1: ID50 Analysis Of Mammalian-Adapted Spirochetes. 
A single C3H/HeN SCID mouse (Harlan) was inoculated with 2x106 B. 
burgdorferi B31 A3.  Two weeks post infection the infected blood was harvested and 
used to inoculate groups of six wild-type C3H/HeN (Harlan) mice with 100 µl of 
undiluted infected blood or 100 µl of infected blood diluted 1:10 or 1:100 in BSK-H 
medium.  The number of live spirochetes in the infected blood and therefore the actual 
spirochete dose in the inoculum was determined by plating the blood in solid BSK 
medium and quantitating the number of colony forming units (Table 3).  In addition, 
groups of six wild-type C3H/HeN mice (Harlan) were inoculated with 5x104, 5x103, 
5x102, 5x101 or 5x100, in vitro grown spirochetes at mid-log phase. The in vitro grown 
spirochetes were confirmed to harbor all plasmids required for infectivity [150]. 
2.4.14.2:  Functional Validation Of The BbIVET System. 
Groups of 6 mice were needle inoculated as described [74] with 1x104 
spirochetes of clone A3 68-1 carrying pBbIVET or pBbIVET-ospCp.  Mouse infection 
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was assessed 3 weeks post inoculation by reisolation of spirochetes from ear, bladder 
and joint tissues as previously described [67, 150]. 
2.4.14.3:  Gene Expression Studies. 
Three mice were needle-inoculated intradermally under the skin of the upper 
back with B. burgdorferi clone B31 A3 at a dose of 1x105 spirochetes.  Three weeks 
post inoculation mouse infection was determined by serology [67, 150] and bladders 
harvested for RNA isolation.  
2.4.14.4:  bbk46 Mutant Infectivity Studies. 
Groups of five mice were needle-inoculated, intradermally under the skin of the 
upper back, with B. burgdorferi clones wild-type (A3-68∆BBE02 [140]), ∆bbk46/vector or 
∆bbk46/bbk46+ at a dose of 1x104 spirochetes.  The number of spirochetes inoculated 
into mice was determined using a Petroff-Hausser counting chamber and verified by 
colony-forming unit (cfu) counts in solid BSK medium. Twelve colonies per inoculum 
were verified by PCR for the presence of the virulence plasmids lp25, lp28-1 and lp36 in 
at least 90% of the individuals in the population. Further, total plasmid content of each 
inoculum was confirmed to be as expected [16, 74, 150]. Mouse infection was assessed 
three weeks post inoculation by serology using total B. burgdorferi lysate, as previously 
described [16] and 300 ng recombinant GST-OspC [135], as previously described [156].  
Spirochetes were reisolated from the inoculation site, ear, bladder and joint tissues, as 
previously described [16].   
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Groups of five immunodeficient C3SnSmn.CB17-Prkdc<scid>/J (Jackson labs stock 
001131) were needle-inoculated with B. burgdorferi clones wild-type (A368∆BBE02 
[140]), ∆bbk46/vector or ∆bbk46/bbk46+ at a dose of 1x104 spirochetes.  80% of the 
inoculum was delivered intraperitoneal and 20% of the inoculum was delivered 
subcutaneous. The inoculum cultures were analyzed as described above.  Mouse 
infection was assessed three weeks post inoculation by reisolation of spirochetes from 
ear, bladder and joint tissues [16]. 
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Table 7: List of primers used in this study 
Primer 
number 
Designation Sequence (5’ – 3’)a 
1 pncA 5’ EcoRI A  cggaattcatgGCACTTATTTTAATAGATATAC 
2 pncA 3’ XbaI  gctctagaTTATATATTAAGCTTACTTTGGCTG 
3 ospC prom 5’ EcoRI  cggaattcTTCTTTTTCATTAATTTGTGCCTCC  
4 ospC prom 3’ EcoRI cggaattcTTAATTTTAGCATATTTGGCTTTGCTTATGTC
G 
5 pUC18R BSV2 AGCGGATAACAATTTCACACAG 
6 pncA prom 3’ seq ACTGTTAGATACTGGCAAAGTGCC 
7 bbk46Fup500 GTTCTTTTATGGAGCAAGCAACTAA 
8 bbk46Rup500 CGGAAGCCACAAGAGGCGACAGACACTATCTTAGTA
CCTCTTCTTAGAATCTG 
9 bbk46Fdown500 GGCGAGATCACCAAGGTAGTCGGCAAATAAATAATA
CTAATCTTAGATAGCTCAGCTTT 
10 bbk46Rdown500 CTAGCTTCACTAGTTTCCCTAGA 
11 flaBpaadA F TGTCTGTCGCCTCTTGTG 
12 flaBpaadA R TTATTTGCCGACTACCTTGGTG 
13 K465’kpn1fwd cggggtaccCTTCCAGTGTAGGCTTTAGTTT 
14 K463’FLAGrev TTAtttatcatcatcatctttataatcTGCCTCAACTGCCTTTCTC 
15 K465’FLAGfwd gattataaagatgatgatgataaaTAAAATGCTTCAAAGGAAAA
TTATGAATGG  
16 K463’C-mycSalIrev acgcgtcgacTTAcagatcttcttcagaaataagtttttgttcATAAGCAG
CTTCATATGCTTTATTT 
17 K465’PCR3fwd CGGGGTACCCTTCCAGTGTAG 
18 K463’PCR3rev ACGCGTCGACTTACAGATCTTCTTCAGAAATA 
19 Lp362908F AGCATTATTTGTACTTCTAGGC 
20 Lp3629013R ACATACTAGACAACAACAAGTC 
21 flaBF3 GCATTAACGCTGCTAATCTTAG 
22 flaBR3 GCATTAATCTTACCAGAAACTCC 
23 recA F AATAAGGATGAGGATTGGTG 
24 recA R GAACCTCAAGTCTAAGAGATG 
25 ospC1 F ACGGATTCTAATGCGGTTTTACCT 
26 ospC1 R CAATAGCTTTAGCAGCAATTTCATCT 
27 flaBp 5’ KpnI gggggtaccTGTCTGTCGCCTCTTGTGGCT 
28 flaBp 3’ BamHI gggggatccGATTGATAATCATATATCATTCCT 
29 bbk46+S 5’ BamHIF cgggatccATGAATTTAATTGCTAAATTATTTATTTTATC
CAC 
30 bbk46-S 5’ BamHIF cgggatcc ATGTGTAACCTATATGATAATCTTGCAGAC 
31 bbk46 3’ XhoIR ccgctcgag TTAATAAGCAGCTTCATATGCTTTATTTAG 
aLowercase indicates all non-B. burgdorferi sequence.  
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CHAPTER THREE: B. BURGDORFERI SURVIVAL IN THE MAMMALIAN 
HOST IS MODULATED BY bbk46 VIA A REGULATORY PATHWAY 
CONTROLLING vlsE EXPRESSION. 
3.1 Introduction 
Borrelia burgdorferi is the etiologic agent of Lyme disease, which is considered to 
be the most prevalent arthropod-borne bacterial disease in the world [157]. These 
spirochetes gain entry into the mammalian host via the bite of infected Ixodes scapularis 
ticks [6]. The pathogen survives efficiently in these two disparate conditions in the 
presence of varying nutritional availabilities, changes in surrounding temperature and 
chemistry and even hostile immune attacks through coordinated differential gene 
expression to best suit its current requirements. Variation in the expression of surface 
proteins is believed to help the spirochetes evade the host immune system and 
establish a long term infection [34-51]. As a result, the elucidation of the mechanisms 
involved in the expression of surface antigens will contribute to an increased 
understanding of the pathogenesis of this disease and may identify novel candidates for 
drug targets and vaccine development. 
In our previous study, bbk46, a gene located on in vivo essential linear plasmid 
36 [16], was identified via an in vivo expression technology (IVET)-based screen to be 
expressed during mouse infection [158]. The deletion of this gene resulted in an 
intermediate infectious phenotype in immunocompetent mice where the spirochetes 
lacking the gene were seroreactive but no live spirochetes were recovered from any of 
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the mouse tissues after three weeks post-inoculation. In immunocompromised mice we 
found that there was no difference between the survival of the mutant and the wild-type 
spirochetes. These data indicated that bbk46 plays an important role in the survival of 
spirochetes within the murine host resulting in the establishment of a stable infection. 
Despite the fact that the B. burgdorferi clone B31 bbk46 gene has a premature stop 
codon in comparison with its orthologs in other B. burgdorferi isolates, transcription was 
detected under in vitro and in vivo growth conditions [158]. This gene is suggested to be 
a member of paralogous gene family 75 on lp36, which also includes bbk45, bbk48 and 
bbk50, all of which are predicted to be surface proteins and some of which have been 
found to have antigenic properties [7, 8, 132, 158]. However, BBK46 is non-
immunogenic and production of BBK46 protein not been detected in vitro [158]. 
Interestingly the phenotype of ∆bbk46 mutant spirochetes is similar to what has been 
described for spirochetes lacking lp28-1 and more specifically the lp28-1 encoded gene 
vlsE [13, 14, 18, 85, 86]. The vlsE gene is required for antigenic variation due to random 
recombination between various intragenic cassettes resulting in protein products having 
varying sequences. This mechanism of recombination has been implicated in the ability 
of the spirochete to evade the adaptive immune response of the host and has been 
shown to be essential for long term infection in mice [86, 90, 92, 159, 160]. Like 
spirochetes lacking vlsE [86], the ∆bbk46 mutants survived until 21 days post 
inoculation within immunocompromised mice but not immunocompetent mice [158]. 
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These data suggest that this gene may be involved in a mechanism of immune 
response evasion used by the spirochetes.  
We now demonstrate that spirochetes lacking bbk46 survive up to week 2 post 
inoculation and are capable of migrating to tissues away from the site of inoculation; 
however, they are eliminated from the mammalian host by week 3. Our data indicate 
that the deletion of bbk46 results in the loss of vlsE gene expression and that bbk46 is 
involved in this regulatory mechanism via its RNA. We found that even though vlsE 
expression was inhibited in the absence of bbk46 alone, the loss of the entire lp36 
plasmid, which encodes bbk46, resulted in no change in vlsE expression, suggesting 
the presence of a gene on lp36 that represses vlsE expression in the absence of bbk46. 
Based upon these findings, we have proposed a novel mechanism of regulation of the 
vlsE gene expression by bbk46 via an lp36 encoded repressor gene. 
 
3.2 Results 
3.2.1: Spirochetes Lacking bbk46 Are Reisolated From Infected Mouse Tissues At 
2 Weeks Post-Inoculation But Are Cleared From The Host By Week 3. 
Previously we found that the spirochetes lacking bbk46 are unable to survive 
within immunocompetent mice three weeks post inoculation, although the mice were 
found to be seropositive for anti-B. burgdorferi antibodies at this same time point [158]. 
Moreover, the bbk46 mutant clone demonstrated no survival defect in 
immunocompromised mice [158]. Together these data suggested that bbk46 contributes 
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to B. burgdorferi’s ability to evade the adaptive immune response of the host. In order to 
obtain a more detailed timeline of the survival and immune clearance of these 
spirochetes within their host we infected groups of 5 mice intra-dermally with B. 
burgdorferi clones wild-type (A3- 68ΔBBE02) [140], Δbbk46/vector or Δbbk46/bbk46+ 
[158] at a dose of 1x104 spirochetes. The infection was then assessed at 48 hours, 1 
week, 2 weeks and 3 weeks post-inoculation via serology and reisolation of spirochetes 
from the inoculation site, ear, bladder and joint tissues (Table 8). At 48 hours post 
inoculation none of the mice were seropositive and live spirochetes were reisolated from 
inoculation site tissues of 3 out of 5 mice inoculated with wild-type spirochetes and 4 out 
of 5 mice inoculated with either Δbbk46/vector or Δbbk46/bbk46+ clones (Table 6). At 1 
week, 2 out of 5 mice inoculated with wild-type spirochetes and 3 out of 5 mice 
inoculated with Δbbk46/vector or Δbbk46/bbk46+ clones were seropositive. At this time 
point spirochetes were reisolated from almost all inoculation site tissues and very few of 
the other tissues. At 2 weeks post inoculation 4 out of 5 mice were seropositive in all 
groups (Table 8). Consistent with previously defined kinetics of spirochete 
dissemination [113, 161], at the 2 week time point live spirochetes were reisolated from 
all tissues of 4 out of 5 mice inoculated with clone Δbbk46/vector. This was comparable 
to the mice inoculated with the wild-type and Δbbk46/bbk46+ clones (Table 8). These 
data suggest that the ∆bbk46 mutant spirochetes do not display a qualitative 
dissemination phenotype. As was expected based on our previous findings [158], at 3 
weeks post-inoculation all 5 mice inoculated with clone Δbbk46/vector were seropositive 
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for anti-B. burgdorferi antibodies but no live spirochetes were isolated from any of the 
tissues analyzed (Table 8). However, 4 out of 5 mice inoculated with wild-type and 5 out 
of 5 mice inoculated with the Δbbk46/bbk46+ clone were seropositive and resulted in 
reisolation of live spirochetes from tissues. 
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Table 8: Spirochetes lacking bbk46 are reisolated from infected mouse tissues at 
2 weeks post-inoculation but are cleared from the host by week 3. 
48 hours post inoculation 
Clone Serologya Positive reisolation of infectious spirochetes from mouse tissuesb 
  Inoculation site Ear Bladder Joint 
wild-type 0/5 3/5 0/5 0/5 0/5 
∆bbk46/ vector 0/5 4/5 0/5 0/5 0/5 
∆bbk46/ bbk46+ 0/5 4/5 0/5 0/5 0/5 
1 week post inoculation 
Clone Serologya Positive reisolation of infectious spirochetes from mouse tissuesb 
  Inoculation site Ear Bladder Joint 
wild-type 2/5 4/5 0/5 1/5 1/5 
∆bbk46/ vector 3/5 4/5 0/5 0/5 1/5 
∆bbk46/ bbk46+ 3/5 5/5 2/5 2/5 3/5 
2 weeks post inoculation 
Clone Serologya Positive reisolation of infectious spirochetes from mouse tissuesb 
  Inoculation site Ear Bladder Joint 
wild-type 4/5 3/5 4/5 5/5 4/5 
∆bbk46/ vector 4/5 4/5 4/5 4/5 4/5 
∆bbk46/ bbk46+ 4/5 3/5 5/5 4/5 4/5 
3 weeks post inoculation 
Clone Serologya Positive reisolation of infectious spirochetes from mouse tissuesb 
  Inoculation site Ear Bladder Joint 
wild-type 4/5 4/5 4/5 4/5 4/5 
∆bbk46/ vector 5/5 0/5 0/5 0/5 0/5 
∆bbk46/ bbk46+ 5/5 3/5 4/5 4/5 4/5 
aDetermined at each time point post-inoculation by serological response to B. 
burgdorferi proteins. 
bNumber of mice positive for spirochete reisolation/ number of mice analyzed  
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These data demonstrated that in the absence of bbk46 spirochetes are able to 
survive within the mouse up to 2 weeks post-inoculation. The mutant spirochetes are 
capable of eliciting an immune response within the host and are capable of migrating to 
other tissues from the site of inoculation. This suggested that clones lacking bbk46 have 
similar kinetics of infection to wild-type spirochetes and that the massive clearance of 
the mutant spirochetes does not occur until after 2 weeks post-inoculation. The 
spirochetes loads in the various tissues at 2 weeks post-inoculation were analyzed in 
order to determine if there was a quantitative difference between the number of 
disseminated spirochetes with and without bbk46. Total DNA was purified from all 
tissues and was analyzed using quantitative real time PCR (qPCR). The spirochete 
numbers were expressed as flaB spirochete DNA copies per 1000 nid1 mouse DNA 
copies (Fig. 12). 
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 Figure: 12: Spirochete loads in harvested tissues from mice inoculated with wild-
type, ∆bbk46/vector or ∆bbk46/bbk46+ clones. 
Quantitative PCR analysis of spirochete loads was carried out in mouse tissues 
collected from groups of 5 mice each at 2 weeks post-inoculation with clones A3- 
68ΔBBE02 (WT), bbk46::flaBp-aadA/ pBSV2G (Δbbk46/ vector) and bbk46::flaBp-aadA/ 
pBSV2G-bbk46 (Δbbk46/ bbk46+) at a dose of 1x104 spirochetes per mouse. 
Spirochete numbers are expressed as flaB spirochete DNA copies per 1000 nid1 
mouse DNA copies (spirochetes/ 1000 nid1).   
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The qPCR data suggested that the number of ∆bbk46/vector spirochetes in the ear, 
heart and inoculation site tissues was lower than the number of wild-type and 
complemented spirochetes. A reduced number of the mutant and complemented clones 
compared to wild-type spirochetes were detected in the infected joint tissues. One 
caveat to interpretation of these data is that the number of spirochetes at the two week 
time point may be below the level of detection. Nonetheless, these data suggest that at 
this time point there are fewer ∆bbk46 mutant spirochetes in infected tissues, including 
the site of inoculation, compared to the wild-type and complemented clones. This trend 
may be a result of impaired ability of the mutant to disseminate and/or to evade the host 
immune response.  
3.2.2: Spirochetes Lacking bbk46 Do Not Show Seroreactivity For The C6 Peptide 
Of VlsE In Mice. 
Our mouse infectivity experiment data indicated that the loss of bbk46 results in a 
defect in a mechanism of evasion of the host immune response. This led us to explore 
any possible changes in the antigenicity of known surface antigens of the bbk46 mutant 
spirochetes. The bbk46 gene is annotated as a member of the gene family 75 along 
with lp36 encoded genes bbk45, bbk48 and bbk50. Although BBK46 protein is 
undetectable in B. burgdorferi [158], members of this family encode putative P37 
lipoproteins [88]. The BBK50 protein has been shown previously to be antigenic [88] 
and BBK48 is a putative surface lipoprotein found to be present in the invasive strains of 
B. burgdorferi [162]. Therefore these putative antigens along with the C6 peptide of 
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VlsE, RevA, DbpA, BBK19, CRASP-2, OspA and OspC were analyzed by immunoblot 
using immune sera obtained from mice prior to inoculation with spirochetes and at 3 
weeks post-inoculation with clones wild-type (A3-68ΔBBE02) [140], Δbbk46/vector or 
Δbbk46/bbk46+ [158]. Strikingly, unlike mice infected with wild-type or bbk46 
complemented spirochetes, mice infected with spirochetes lacking bbk46 did not 
develop antibodies against the C6 peptide of the surface antigen VlsE (Fig. 13). No 
immunogenic differences were detected for any of the other protein antigens. 
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 Figure 13: Spirochetes lacking bbk46 are non-seroreactive for the C6 VlsE 
peptide in mice. 
Immunoblot analysis of sera collected pre-inoculation and 3 weeks post-inoculation from 
groups of five C3H/HeN mice inoculated with clone A3-68ΔBBE02 (wild-type), 
bbk46::flaBp-aadA/ pBSV2G (Δbbk46/ vector) and bbk46::flaBp-aadA/ pBSV2G-bbk46 
(Δbbk46/ bbk46+) at a dose of 1x104 spirochetes per mouse. A panel of recombinant N-
terminal GST fusion proteins consisting of known as well as predicted antigenic 
lipoproteins, was used for testing seroreactivity. The positions of markers to the left of 
the panel depict protein standard molecular masses in kilodaltons. 
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All sera were non-reactive to rGST-BBK46, consistent with previous findings 
[158], rGST-BBK45, rGST-CRASP-2 and rGST-OspA, which was comparable to the 
reactivity with the negative control, GST alone and the reactivity of the pre-immune 
sera. All post-inoculation sera were found to be reactive with rGST-BBK48, rGST-
BBK50, rGST-RevA, rGST-DbpA, and rGST-OspC. All immune sera demonstrated 
similar levels of reactivity to the positive control B. burgdorferi total protein lysate. 
To further evaluate the change in the seroreactivity profile of spirochetes lacking 
bbk46, we analyzed purified recombinant GST-C6 peptide via immunoblot with mouse 
sera obtained at weeks 1, 2 and 3 post-inoculation with clones wild-type (A3- 
68ΔBBE02) [140], Δbbk46/vector or Δbbk46/bbk46+ [158] (Fig. 14). No reactivity to the 
C6 antigen was detected at all weeks in mice inoculated with the ∆bbk46/vector clone. 
Mice inoculated with the wild-type and ∆bbk46/bbk46+ clones showed antibody 
reactions to rGST-C6 at week 3 but not at weeks 1 or 2. 
Previous studies have shown that lp36 is essential for mammalian infectivity and 
that re-introduction of bbk17 alone into spirochetes lacking the entire lp36 plasmid 
restores infectivity to that of wild-type [16]. These data appeared to be in contrast to our 
findings herein, that spirochetes lacking only bbk46 are non-infectious 3 weeks post-
inoculation. In an attempt to more clearly understand the mechanism of bbk46-
dependent expression of vlsE and the ability of lp36-/bbk17+ spirochetes to infect mice 
despite lacking bbk46, we tested sera from mice inoculated with spirochetes lacking the 
entire lp36, except for the infectivity essential gene bbk17, with purified rGST-C6 
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peptide. We found that these sera were positive for antibodies specific for rGST-C6 
peptide (Fig 15). These data suggested that in the absence of the entire lp36 plasmid 
the C6 peptide of VlsE is immunoreactive on the surface of these spirochetes. 
Moreover, these findings indicated that spirochetes lacking bbk46 do not display VlsE 
on their outer membrane surface or they display it in a manner that is not antigenic like 
the VlsE of wild-type or bbk46 complemented spirochetes. We confirmed that the 
spirochetes reisolated from the mice infected with spirochetes lacking bbk46 were lp28-
1 and/or vlsE positive by PCR amplification (data not shown). 
VlsE is a surface antigen implicated in protection of B. burgdorferi from the host 
adaptive immune response via a mechanism of antigenic variation [86, 90, 92, 159, 
160]. Previous studies have demonstrated that loss of the linear plasmid 28-1, which 
contains vlsE, results in an infectious phenotype similar to the one we have observed in 
spirochetes lacking bbk46. The loss of seroreactivity to VlsE in the absence of bbk46 
suggested that the VlsE protein may not present on the surface of the spirochetes 
lacking bbk46 and that the expression of the vlsE gene might be lost in the absence of 
bbk46. In addition, the uninhibited immunogenicity of VlsE seen in spirochetes lacking 
the entire lp36 suggested the possibility of a repressor gene on this plasmid that may 
downregulate the expression of vlsE in the absence of bbk46 and the effect of which is 
not seen when the entire plasmid is absent.   
85 
 
 Figure 14: Spirochetes lacking bbk46 are not seroreactive for VlsE (C6 peptide) in 
mice up to 3 weeks post inoculation. 
Immunoblot analysis of sera collected at 1 week, 2 weeks and 3 weeks post-inoculation 
from groups of five C3H/HeN mice inoculated with clone A3-68ΔBBE02 (WT), 
bbk46::flaBp-aadA/ pBSV2G (Δbbk46/ vector) and bbk46::flaBp-aadA/ pBSV2G-bbk46 
(Δbbk46/ bbk46+) at a dose of 1x104 spirochetes per mouse. Purified, recombinant 
GST-C6 was used for testing seroreactivity. The positions of markers to the left of the 
panel depict protein standard molecular masses in kilodaltons. 
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 Figure 15: Spirochetes lacking the entire lp36 plasmid are seroreactive for C6 
peptide of VlsE. 
Immunoblot analysis of sera collected at 3 weeks post inoculation from C3H/HeN mice 
inoculated with clone A3-68ΔBBE02 (WT), bbk46::flaBp-aadA/ pBSV2G (Δbbk46/ 
vector) and bbk46::flaBp-aadA/ pBSV2G-bbk46 (Δbbk46/ bbk46+) at a dose of 1x104 
spirochetes per mouse and A3-M9-lp36-/lp36+(lp36-/lp36+) and A3-M9- lp36-/bbk17+ 
(lp36-/bbk17+) at a dose of 1x105 per mouse. Purified, recombinant GST-C6 was used 
for testing seroreactivity (C6).  Purified recombinant GST-OspC (OspC) and B. 
burgdorferi total protein lysate (B. burgdorferi lysate) were positive controls. Pre-
immune serum (pre-immune) collected prior to mouse inoculation was used as the 
negative control.  The positions of markers to the left of the panel depict protein 
standard molecular masses in kilodaltons. 
3.2.3: vlsE Expression Is Lost In Spirochetes Lacking bbk46 Only But Not The 
Entire lp36 Plasmid. 
In order to test the hypothesis that bbk46 is involved in the regulation of vlsE 
expression, we analyzed the expression of the vlsE gene in the ∆bbk46 mutants via 
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endpoint reverse transcription (RT)-PCR and by quantitative RT-PCR. In the absence of 
the bbk46 gene the vlsE transcript was below the level of detection by end-point RT-
PCR; whereas, expression of the vlsE gene was restored with the complementation of 
the bbk46 gene (Fig. 16A). Similarly, qRT-PCR analysis demonstrated that the level of 
vlsE expression was reduced more than 10,000 fold in the absence compared to the 
presence of bbk46 (Fig. 16B). These data suggest that vlsE expression is regulated 
either directly or indirectly by bbk46 and that the inability of the spirochetes lacking 
bbk46 to mount a long-term infection in the mouse may be due to the loss of vlsE 
expression.  
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 Figure 16: vlsE expression is significantly downregulated in spirochetes lacking 
bbk46 alone. 
Total RNA was isolated from log phase in vitro grown A3-68ΔBBE02 (WT), 
bbk46::flaBp-aadA/ pBSV2G (Δbbk46/ vector) and bbk46::flaBp-aadA/ pBSV2G-bbk46 
(Δbbk46/ bbk46+), A3-M9-lp36-/lp36+ ( lp36-/lp36+), A3-M9-lp36-/pBSV2Gv(lp36-/vector)  
and A3-M9-lp36-/bbk17+ (lp36-/bbk17+) B. burgdorferi. RNA was reverse transcribed to 
cDNA using random hexamer primers. The expression of vlsE, bbk46, and recA was 
obtained using endpoint RT-PCR (A). B. burgdorferi genomic DNA was used as positive 
control (gDNA) and the negative control was the reaction mix with no template DNA 
(NTC). The positions of markers to the left of the panel depict DNA standard molecular 
sizes in basepairs. The expression was also quantified using quantitative reverse 
transcription polymerase chain reaction (qRT-PCR) (B). The mRNA levels of the vlsE 
gene transcripts were normalized to that of the constitutive recA gene. The data 
represent the average of triplicate qRT-PCR analyses. Error bars represent the 
standard deviation from the mean.  
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We also analyzed the expression of vlsE via end-point RT-PCR, in lp36- and 
lp36-/bbk17+ clones that were grown in vitro (Fig. 16A). Consistent with our observation 
that lp36-/bbk17+ spirochetes produce immunoreactive VlsE protein, we detected vlsE 
transcription in spirochetes lacking lp36 as well as in the lp36-/bbk17+ clone. As 
expected, the expression of bbk46 was not detected in the lp36- and the lp36-/bbk17+ 
clones. Similar results were obtained using qRT-PCR analysis (Fig. 16B).  
These data demonstrated that in the absence of the entire lp36 plasmid, vlsE 
expression is comparable to that detected in wild-type spirochetes. This expression 
pattern was also observed when only the bbk17 gene on lp36 was present. In contrast, 
vlsE expression was severely down regulated in spirochetes lacking the lp36-encoded 
bbk46 gene alone (Fig. 16). These findings suggested the possibility of the presence of 
an additional regulatory gene on lp36 with repressor function that downregulates the 
expression of vlsE in the absence of bbk46 and that, in turn, itself maybe repressed by 
bbk46. Hence, vlsE expression is unhindered in wild-type as well as lp36- spirochetes 
but is repressed in the absence of bbk46 alone. 
3.2.4: bbk46 appears to function as an RNA. 
We found that vlsE expression was lost in the absence of bbk46. We have also 
been unable to detect a protein product for the bbk46 gene, although bbk46 gene 
expression has been detected [158]. These findings suggested the possibility of bbk46 
functioning as an RNA molecule. In order to better understand if bbk46 was functioning 
as a regulatory RNA or a regulatory protein to control vlsE expression we introduced a 
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mutation at the putative start codon of the BBK46 open reading frame in order to inhibit 
bbk46 translation.  The ATG coding for methionine was replaced by TTT that codes for 
phenylalanine to create the bbk46ATG-TTT mutant (Fig.17A). It was expected that this 
would result in transcription and production of mRNA from the bbk46 ORF; however, 
due to the mutation at the start codon, translation would be obstructed and there would 
be no protein production. Since BBK46 protein production in B. burgdorferi has not been 
detected, production of the BBK46ATG-TTT mutant was examined in E.coli in order to 
determine if this mutation abolished translation of bbk46. Total protein was extracted 
from E.coli and the expression of the recombinant protein was tested via immunoblot 
(Fig. 17B) using anti-FLAG antibodies. In contrast to wild-type BBK46-FLAG, which was 
produced in E. coli, no BBK46ATG-TTT-FLAG protein was detected in E.coli expressing 
the bbk46ATG-TTT mutant construct (Fig. 17A). Based on these results it appeared that 
the bbk46ATG-TTT mutant was unable to produce a detectable protein. 
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 Figure 17: BBK46 protein is not detectable in E. coli after mutation of the start 
codon. 
Schematic representation of the bbk46ATG-TTT mutant (A). The ATG coding for 
methionine was replaced by TTT that codes for phenylalanine to create the bbk46ATG-TTT 
mutant. Protein lysates were prepared from B. burgdorferi ∆bbk46 or E.coli harboring 
either pBSV2G bbk46p-bbk46-FLAG-cMyc (bbk46p-bbk46) or pBSV2G flaBp-bbk46-
FLAG-cMyc (flaBp-bbk46) and E.coli harboring pBSV2G bbk46p- bbk46ATG-TTT-FLAG-
cMyc (bbk46p-bbk46ATG-TTT) and analyzed by immunoblot (B). The blot was probed with 
αFLAG antibodies. The positions of markers to the left of the panel depict protein 
standard molecular masses in kilodaltons. 
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 Figure 18: vlsE transcription is detected in bbk46ATG-TTT mutant spirochetes. 
Total RNA was isolated from log phase in vitro grown bbk46::flaBp-aadA/ pBSV2G-
bbk46ATG-TTT+ (∆bbk46/bbk46ATG-TTT+), bbk46::flaBp-aadA/ pBSV2G (Δbbk46/ vector) 
and bbk46::flaBp-aadA/ pBSV2G-bbk46 (Δbbk46/ bbk46+) B. burgdorferi. RNA was 
reverse transcribed to cDNA using random hexamer primers. The expression of bbk46, 
vlsE and recA were obtained using endpoint RT-PCR (A). The positions of markers to 
the left of the panel depict DNA standard molecular sizes in basepairs. Quantitative 
analysis of bbk46, vlsE and recA expression was carried out using quantitative reverse 
transcription polymerase chain reaction (qRT-PCR) (B). The mRNA levels of the vlsE, 
and bbk46 gene transcripts were normalized to that of the constitutive recA gene. The 
data represent the average of triplicate qRT-PCR analyses. Error bars represent the 
standard deviation from the mean.  
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To confirm that the bbk46ATG-TTT gene was expressed in B. burgdorferi , total 
RNA was extracted from in vitro grown ∆bbk46/bbk46ATG-TTT spirochetes and analyzed 
for the expression of vlsE using end point RT-PCR (Fig. 18). Expression of the 
bbk46ATG-TTT mutant gene in spirochetes lacking bbk46 resulted in restoration of vlsE 
expression. These data suggested that bbk46 appears to function as an RNA and not 
as a protein, to control the expression of vlsE (Fig. 18). 
3.2.5: Reintroduction Of 12 lp36-encoded Genes To Spirochetes Lacking The 
Entire lp36 Plasmid Does Not Result in Down Regulation Of The vlsE Transcript.  
We have demonstrated that vlsE expression is repressed in the absence of 
bbk46. We have also shown that in the absence of the entire lp36 plasmid, which 
contains the bbk46 locus, there is no detectable loss of vlsE expression. These data 
suggest the possibility of an, as of yet unknown, gene located on lp36 that acts as a 
repressor of vlsE transcription in the absence of bbk46. Our next strategy was to try and 
identify this repressor gene. Our approach has been to add back different fragments of 
lp36 plasmid to a clone lacking the entire lp36 plasmid in order to create a panel of 
clones that contain different regions of lp36 in the absence of bbk46. We expected that 
if we are able to introduce the repressor gene into a clone lacking all other lp36 genes 
including bbk46, this gene would be active and vlsE expression would be lost. To date, 
5 different clones have been created spanning 11 different genes on lp36, as well as the 
bbk17 gene (Fig.19). 
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The genes inserted into the 5 clones were bbk05 in clone B, bbk09, bbk08 and 
putative lipoprotein bbk07 in clone C, bbk12, bbk13 (SIMPL family protein), bbk14 and 
bbk15 in clone I, bbk50 (immunogenic P37 family protein) and bbk49 (putative outer 
membrane protein) in clone G and bbk53 and bbk52 (putative lipoprotein) in clone H [7]. 
These clones were grown in vitro to log phase and total RNA was extracted. The 
expression of vlsE was analyzed using endpoint RT-PCR. We observed no loss or 
reduction of vlsE expression in any of the 5 clones (Fig. 20). These data suggested that 
the repressor was not present in these regions of linear plasmid 36.   
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 Figure 19: Schematic representation of the shuttle vectors, each containing 
different fragments of linear plasmid 36 in addition to bbk17. 
Different fragments B, C, G, H and I containing genes bbk05, bbk07-bbk08-bbk09, 
bbk49-bbk50, bbk0059-bbk52-bbk53 and bbk12-bbk13-bbk15 respectively, of linear 
plasmid 36 were introduced into a shuttle vector pBSV2* [127] containing the bbk17 
gene. 
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 Figure 20: Reintroduction of 12 different genes into spirochetes lacking the entire 
lp36 plasmid does not result in down regulation of the vlsE transcript. 
Total RNA was isolated from log phase in vitro grown B. burgdorferi clones lacking lp36 
with distince lp36-encoded genes added back. RNA was reverse transcribed to cDNA 
using random hexamer primers and in the presence (+) or absence (-) of reverse 
transcriptase (RT). The expression of vlsE and recA were obtained using endpoint PCR 
(A). The positions of markers to the left of the panel depict DNA standard molecular 
sizes in basepairs. B. burgdorferi genomic DNA was used as positive control (gDNA) 
and the negative control was the reaction mix with no template DNA (NTC). The 
expression was also quantified using quantitative reverse transcription polymerase 
chain reaction (qRT-PCR) (B). The mRNA levels of the vlsE gene transcripts were 
normalized to that of the constitutive recA gene. These data represent the average of 
triplicate qRT-PCR analyses. Error bars represent the standard deviation from the 
mean.  
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3.3 Discussion 
The persistence of Borrelia burgdorferi throughout its infectious cycle is attributed 
to its ability to vary gene expression in response to environmental conditions [51]. 
Evasion of the host adaptive immune response is one of the survival strategies of these 
spirochetes and it is believed that one of the mechanisms involved in immune evasion is 
variation in the patterns of surface antigenic proteins [6].  
We previously demonstrated that bbk46, a gene located on linear plasmid 36, 
was required for long term infectivity in mice and suggested that this gene contributes 
towards B. burgdorferi’s ability to evade the host adaptive immune response [158]. We 
now demonstrate that the spirochetes lacking bbk46 survive up to two weeks post-
inoculation in mice (Table 8). Consistent with previous findings [158] the mutant 
spirochetes were undetectable in immunocompetent mice at three weeks post-
inoculation. These findings demonstrate that bbk46 is not required for the initial stages 
of B. burgdorferi infection. This gene is, however, essential for persistent survival of the 
spirochetes in infected tissues, likely through a mechanism that contributes to the ability 
of B. burgdorferi to evade the host humoral immune response. The mutant spirochetes 
are able to migrate to and survive within tissues that are distant from the inoculation 
site.  Although our data suggest that the numbers of spirochetes lacking bbk46 in 
infected mouse tissues are lower than that of wild-type spirochetes at the two week time 
point of infection. Subsequently, between weeks 2 and 3 post-inoculation, the host 
adaptive immune response targets the spirochetes and those that lack bbk46 are 
98 
 
unable to evade this immune attack and can no longer survive. Immunoblot and gene 
expression analyses showed that the spirochetes lacking bbk46 demonstrated 
significant downregulation of the critical surface exposed antigen, vlsE. Together these 
data suggest that bbk46 may be involved in B. burgdorferi’s ability to evade the host 
immune response through the regulation of the surface exposed antigen vlsE.  
vlsE is an outer surface protein that demonstrates antigenic variation of its 
protein product and has been implicated in the process of evasion of the host adaptive 
immune response by B. burgdorferi. [86, 90, 91]. It is a gene located on lp28-1 and 
contains a central expression locus that randomly recombines with adjacent silent 
cassettes causing the production of proteins that have varying sequences resulting in 
different antigenic properties [92, 159, 160]. This mechanism of antigenic variation has 
been shown to only occur in the mammalian host and to be essential for evading the 
host immune response and the long term survival of spirochetes within the host [13, 14, 
18, 85, 86, 90-93]. Surprisingly, the only essential protein factors for antigenic switching 
identified so far have been the Holiday Junction Helicase peptides RuvA and RuvB [90, 
91]. A recent study identified pentanucleotide G- runs within the direct repeat regions of 
the vls locus [163] suggesting the formation of G4 DNA structures, which may be 
involved in the regulation of the antigenic switching between the central expression 
locus and the silent cassettes. Antigenic variation has been extensively studied in other 
organisms, particularly in Neisseria gonorrhea [164-168] . Several different factors 
involved in homologous recombination, DNA repair and factors involved in Holiday 
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junction processing pathways have been found to be essential for its antigenic switching 
mechanism of the N. gonorrhea pilin gene [164-168].  
There are a few studies that have investigated vlsE gene expression. One such 
study found that pH and temperature changes influence expression of vlsE in vitro and 
they identified DNA-protein interactions with the promoter region of vlsE, suggesting 
that, yet to be identified, regulatory proteins may control vlsE expression [169]. This 
study identified 37 bp region upstream of the vlsE transcription start site to be a minimal 
promoter important for pH dependent regulation of transcription and additional 5’ DNA 
regions were found to be required for temperature effects [169] . It was found that at 
23oC, bacteria expressed higher levels of VlsE than those cultured at 34oC, irrespective 
of whether the pH was 6.4 or 7. This work also demonstrated the highest expression of 
VlsE in bacteria cultured at pH 8.0 at either 23oC or 34oC.  A recent study demonstrated 
that the DNA binding protein SpoVG binds within the vlsE open reading frame; however, 
its role in vlsE regulation is still unknown [170]. It has also been shown that vlsE 
expression was increased in in vitro cultured B. burgdorferi that were grown in the 
presence of human endothelial or neuronal cells suggesting the influence of host factors 
on regulating vlsE expression [171]. Moreover, a unique inverted repeat sequence has 
been identified in the promoter region of the vlsE locus that is predicted to form a stable 
stem loop structure [171]. Such structures have also been identified in eukaryotic or 
viral genomes and are believed to be involved in various processes like promoter 
recognition, plasmid segregation and replication or regulation of gene expression [172-
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174]. It is still unclear whether the expression of the vlsE gene itself and the 
recombination events leading to antigenic switching are mutually exclusive processes or 
might be related and as a result regulated under the same overall mechanism. This is 
significant since previous studies have mainly targeted the regulation of the process of 
recombination and not the expression of the gene itself. Our findings, on the other hand, 
appear to be the first instance of identification of a genetic factor influencing the 
expression of the vlsE gene. We find that, in the absence of bbk46, vlsE expression is 
significantly downregulated and accompanied by loss of long term infection in mice 
suggesting that bbk46 might indeed be involved in an, as of yet unknown, mechanism of 
regulation of vlsE expression. Bankhead et al., (2007) [86] found that a non-switching 
vlsE mutant was cleared from infected mice between weeks 2 and 3 post inoculation. In 
addition they point out that this non-switching mutant was cleared from infected mice at 
a faster rate than the mutants that lacked the vlsE gene and they suggest that this 
indicates a role of vlsE antigenic switching in adaptive immune response evasion. It 
would seem that a non-switching mutant would be able to present the one non-variant 
isoform which would be identified by the host thus furthering the idea that non-switching 
mutants would show seroreactivity for the C6 peptide of VlsE. We observed no 
seroreacivity for the C6 peptide in mice infected with the ∆bbk46 mutant, suggesting 
again, that this mutant does not present any form of VlsE on its cell surface and that 
bbk46 deletion downregulates the expression of the vlsE gene.  
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Linear plasmid 36 is essential for spirochete infectivity [16]. Introduction of bbk17, 
an adenine deaminase encoded on lp36, into spirochetes lacking lp36 led to the 
restoration of infectivity in these spirochetes [16]. There appears to be a dichotomy 
between these findings and our current data, wherein spirochetes lacking bbk46 are 
cleared from the murine hosts by week three post inoculation, whereas spirochetes 
expressing only bbk17 and lacking all other lp36-encoded genes including bbk46 
demonstrated a wild-type infectious dose [16]. Our subsequent experiments aimed at 
reconciling these differences showed us that despite the fact that the spirochetes 
lacking the entire lp36 plasmid did not show expression of bbk46, they showed no 
inhibition of vlsE expression. We also found that serum from mice infected with lp36-
/bbk17+ mutant spirochetes contained antibodies against VlsE. Together these data 
suggest the presence of another factor on lp36 that appears to repress vlsE expression 
in the absence of bbk46 alone. However, when the entire lp36 is absent, so is the 
putative repressor and as a result vlsE expression is uninhibited. In the light of these 
findings, we propose a mechanism of regulation of vlsE expression that involves bbk46 
as a repressor of another unknown gene ’x’ located on linear plasmid 36 that, in turn, 
acts as a repressor of vlsE (Fig. 21). We propose that bbk46, directly or indirectly, acts 
as a repressor of gene ‘x’ and inactivates it. When repressor gene ‘x’ is inactive vlsE is 
expressed. However, if bbk46 is absent, then gene ‘x’ is activated and downregulates 
the expression of vlsE as seen in the mutants that do not contain bbk46. If the entire 
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lp36 is absent then neither the repressor gene’x’ is present nor is bbk46 and so vlsE 
expression remains unrestricted as seen in the spirochetes lacking the entire lp36. 
 
 
Figure 21: Putative model of regulation of vlsE expression via bbk46 and 
unknown gene 'x'. 
A schematic representation of a proposed mechanism of regulation of the vlsE gene 
where bbk46 acts as a repressor of an unknown gene ‘x’ located on lp36. In the 
absence of bbk46 activity gene ‘x’ acts as a repressor of vlsE downregulating its 
expression.  When bbk46 is active it represses gene ‘x’ in a direct or indirect manner, 
allowing wild-type expression of vlsE.  
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 Our findings suggest that the regulatory function of bbk46 is carried out via its 
RNA product. A protein product for this gene has yet to be detected [158]. Also, the 
translation mutant, bbk46ATG-TTT showed no detectable BBK46 protein product but 
produced transcript comparable to wild-type levels and displayed uninhibited expression 
of vlsE. There is very limited information about the mode of function or even the 
existence of small regulatory RNAs (sRNAs) within B. burgdorferi. [7, 175-177] sRNAs 
have been studied in E.coli [178] and are known to function by binding their target 
mRNA to either induce or inhibit translation and might also be involved in binding and 
sequestration of proteins. They are known to interact with the sm-like protein Hfq, which 
helps stabilize the binding of the sRNAs to their target mRNA and acts like a chaperone 
protein [179, 180]. Recently an Hfq homolog was found in B. burgdorferi and it was 
shown to be similar in its tertiary structure but varying in sequence similarity to its 
homologs in other species [181]. It was shown to influence the expression of the 
regulatory gene rpoS in a temperature dependent manner via the small regulatory RNA 
DsrABb [181] . Further studies are needed in order to identify the mechanism of function 
of the bbk46 transcript. Our findings suggest that this gene might have a role as a 
regulatory RNA and further analysis of this possibility is essential for a better 
understanding of not only bbk46 function but also understanding of regulatory RNAs in 
Borrelia burgdorferi. 
We have proposed a possible mechanism of regulation bbk46-dependent vlsE 
regulation; however, we can merely speculate about the factors controlling expression 
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of bbk46 itself. We demonstrated previously that bbk46 expression is dramatically 
increased in spirochetes isolated from in vivo samples as compared to in vitro grown 
spirochetes [158]. We also found that bbk46 expression was independent of RpoS 
regulation [158]. Perhaps the induction of this gene is influenced by the environment 
itself. Various host factors such as different cellular and tissue components that interact 
with the invading spirochetes and perhaps even immune response factors might act as 
triggers inducing the increased expression of this gene so that it can play its part within 
the mechanism of immune protection. Currently, based on our proposed mechanism of 
regulation, we are in the process of identifying the gene on lp36 that acts as a repressor 
of vlsE expression. Our initial findings have been restricted to a few genes on lp36 and 
we have determined that B. burgdorferi clones lacking lp36 and containing bbk17 along 
with either genes bbk05, bbk07,bbk08, bbk09, bbk12, bbk13, bbk15, bbk49, bbk50, 
bbk0059, bbk52 or bbk53 do not show a downregulation of vlsE expression (Fig. 17), 
which suggests that none of these genes is the putative repressor. Identification of the 
putative lp36-encoded repressor of vlsE is an area of ongoing research. 
In conclusion, we have demonstrated that spirochetes lacking bbk46 can survive 
within the mammalian host up to 2 weeks and are eliminated from the host by week 3 
post-inoculation. We have also shown that bbk46 produces an RNA, which appears to 
be involved in regulation of vlsE expression and we have proposed a regulatory 
mechanism involving a putative repressor gene located on lp36. These findings have 
broadened our understanding of the role of lp36 in mammalian infectivity.  Our current 
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and future work is directed at identifying the putative repressor of vlsE expression, 
which would be invaluable for our understanding of the mechanisms involved in the 
expression of this gene.  
 
3.4 Materials And Methods 
3.4.1: Ethics Statement. 
The University of Central Florida is accredited by the International Association for 
Assessment and Accreditation of Laboratory Animal Care. Protocols for all animal 
experiments were prepared according to the guidelines of the National Institutes of 
Health and approved by the UCF’s Institutional Animal Care and Use Committee. 
3.4.2: Bacterial Clones And Growth Conditions. 
All B. burgdorferi clones used were derived from clone B31. Low passage B. 
burgdorferi complemented clones were generated from the mutant clone Δbbk46::flaBp-
aadA [158], that lacks the bbk46 gene. B. burgdorferi clones containing various lp36 
fragments were generated, using non-infectious clone B31-A [182] and A3-M9 lp36- that 
lacks lp36, cp9 and lp21 [16]. B. burgdorferi was grown in liquid Barbour-Stoenner-Kelly 
(BSK) II medium supplemented with gelatin and 6% rabbit serum [151] and plated in 
solid BSK medium as previously described [152, 153]. All spirochete cultures were 
grown at 35oC supplemented with 2.5% CO2. Kanamycin was used at 200 μg/ml, 
streptomycin was used at 50 μg/ml and gentamicin was used at 40 μg/ml, when 
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appropriate. All cloning steps were carried out using DH5α E. coli, which were grown in 
LB broth or on LB agar plates containing 50 μg/ml kanamycin or 10 μg/ml gentamycin. 
3.4.3: Mouse Infection Experiments.  
3.4.3.1: Time course of infectivity of the bbk46 mutant. 
6-8 week old C3H/HeN female mice (Harlan) were used for all experiments. 
Groups of five mice were needle-inoculated, intra-dermally under the skin of the upper 
back [14], with B. burgdorferi clones wild-type (A3-68ΔBBE02) [140], Δbbk46/vector or 
Δbbk46/bbk46+ [158] at a dose of 1x104 spirochetes. The number of spirochetes 
inoculated into mice was determined using a Petroff-Hausser counting chamber and 
verified by colony-forming unit (cfu) counts in solid BSK medium. Twelve colonies per 
inoculum were verified by PCR for the presence of the virulence plasmids lp25, lp28-1 
and lp36 in at least 90% of the individuals in the population. Further, total plasmid 
content of each inoculum was confirmed to be as expected [16, 74, 150]. Mouse 
infection was assessed at 48 hours, 1 week, 2 weeks and 3 weeks post inoculation by 
serology and re-isolation of spirochetes from inoculation site, ear, bladder and/or joint 
tissues, as previously described [16]. 
3.4.3.2: Seroreactivity towards VlsE-C6 in lp36- mutant spirochetes.  
Groups of 3 mice were needle inoculated as described in [74] with B. burgdorferi 
clones lp36-/lp36+ and lp36-/bbk17+ [16] at a dose of 5x103 spirochetes per mouse. The 
number of spirochetes inoculated into mice was determined using a Petroff-Hausser 
counting chamber and verified by colony-forming unit (cfu) counts in solid BSK medium. 
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Twelve colonies per inoculum were verified by PCR for the presence of the virulence 
plasmids lp25, lp28-1 and lp36 in at least 90% of the individuals in the population. 
Further, total plasmid content of each inoculum was confirmed to be as expected [16, 
74, 150]. Sera was collected at 3 weeks post inoculation, as previously described [74]. 
3.4.4: Genomic DNA Extraction From Tissues.  
Spirochete DNA was isolated from infected mouse tissues, as previously 
described. [154, 183] Briefly, B. burgdorferi-infected mouse hearts, ears, skin from 
inoculation site, and joint tissues were collected 2 weeks post-inoculation (see above). 
The hearts were manually macerated with sterile scalpels and then placed in 
Collagenase A (1 mg/ml). Ears, skin from inoculation site and joints were directly placed 
in Collagenase A (1 mg/ml) and all organs were incubated at 37oC for 4 hours. 
Proteinase K (0.2 mg/ml) was added to all tubes and they were then placed at 55oC for 
overnight incubation. 2.5 ml each of phenol and chloroform were added to each tube 
followed by vigorous shaking. The samples were centrifuged at 3600 rpm at 25oC for 20 
minutes. From each tube, the clear top layer of liquid (approximately 4.5 ml) containing 
the DNA was transferred to a new tube. 5 ml of 200 proof ethanol was added to each 
tube followed by vigorous shaking. Tubes were incubated at -20oC for 2 hours followed 
by centrifugation at 3600 rpm at 4oC for 20 minutes. The supernatant was discarded 
and the pellet was allowed to dry at room temperature. The pellet was resuspended in 2 
ml of sterile water. 20µl of 1 mg/ml of DNase free RNase was added to each tube and 
then incubated at 37oC for 1 hour. 1 ml each of phenol and chloroform were added to 
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each tube and shaken vigorously. The tubes were centrifuged at 3600 rpm at 25oC for 
20 minutes. Again, the top layer of liquid, containing the DNA, was transferred to new 
tubes. 2ml of chloroform was added to each new tube followed by vigorous shaking and 
then centrifugation at 3600 rpm at 25oC for 20 minutes. The top layer of liquid was 
transferred to new tubes. 1M NaCl was added to each tube to get final concentration of 
0.2M. 5 ml of 200 proof ethanol was added to each tube followed by vigorous shaking. 
Tubes were incubated at -20oC overnight. Samples were then centrifuged at 3600 rpm 
at 4oC for 20 minutes. The supernatant was discarded and the pellets were allowed to 
dry at room temperature. Pellets were resuspended in 100 µl of Tris-EDTA buffer (pH 
8.0). The samples were then purified using the Qiaquick PCR purification kit (Qiagen) 
and the DNA was eluted in 50 µl of Qiagen Elution buffer buffer. All samples were 
stored at -20oC. 
3.4.5: Quantitation Of Spirochete Loads In Mouse Tissues.  
Total DNA isolated from infected mouse tissues was used to quantify B. 
burgdorferi loads within the tissue extracts. Real-time quantitative PCR reactions were 
carried out using 50 µg of DNA per reaction, iTaq Supermix (Bio-rad) and with IDT 
Primetime Standard qPCR Assay Primers/Probe mix for the flaB gene (B. burgdorferi 
chromosome) (primers 1137 and 1138, probe 1139) (Table 9) and the mouse nidogen1 
gene [184] (primers 1140 and 1141, probe 1142) (Table 9) using an Applied Biosystems 
7500 instrument. Samples were analyzed in triplicate and the spirochete burden was 
expressed as flaB spirochete DNA copies per 1000 nid1 mouse DNA copies. The flaB 
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primers were optimized to maximum efficiency using a standard curve with B31 A3 B. 
burgdorferi genomic DNA at concentrations of 106 spirochetes/ 5 µl, 105 spirochetes/ 5 
µl, 104 spirochetes/5 µl, 103 spirochetes/ 5 µl, 102 spirochetes/ 5 µl and 101 spirochetes/ 
5 µl. The nid1 primers were optimized using plasmid DNA containing a cloned copy of 
the nid1 gene (REFENCE the lp36 paper) at concentrations 5.5 x106 copies/ 5 µl, 5.5 
x105 copies/ 5 µl, 5.5 x104 copies/ 5 µl, 5.5 x103 copies/ 5 µl and 5.5 x102 copies/ 5 µl. 
3.4.6: Cloning, Purification And Seroreactivity Analysis Of Recombinant GST-
Tagged Proteins. 
In-frame glutathione S-transferase (GST) fusion proteins lacking their putative 
signal sequences were generated for BBK45, BBK48, BBK50, VlsE (C6), RevA, DbpA, 
BBK19, CRASP-2 and OspA. The above targets were PCR amplified using primer pairs, 
1053 and 1054, 1045 and 1046, 1043 and 1044, 1022 and 1023,1143 and 1144, 1145 
and 1146, 1147 and 1148, 1149 and 1150, and 1151 and 1152, respectively (Table 9), 
Phusion polymerase (New England Biolabs) and B. burgdorferi genomic DNA. The 
clones were generated and proteins purified as described previously [135]. 
Approximately 1 µg of rGST-BBK46 [158], rGST-BBK45, rGST-BBK48 and rGST-
BBK50, and 150 ng of the remaining recombinant proteins along with rGST-OspC [135] 
were separated by SDS-PAGE, transferred to a nitrocellulose membrane and analyzed 
by immunoblot for seroreactivity using immune sera as previously described [135]. The 
sera were collected, pre-inoculation, and at 1 week, 2 weeks and 3 weeks post 
inoculation, from mice infected with 1x104 wild-type Δbbk46/vector and 
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Δbbk46/bbk46+.B. burgdorferi, clones. The sera were also collected, pre-inoculation, 
and at 3 weeks post inoculation, from mice infected with lp36-/ lp36+ and lp36-/ 
bbk17+.B. burgdorferi clones. Controls included 1 µg of GST alone and total protein 
lysates generated from B. burgdorferi B31 A3. 
3.4.7: RNA Isolation From In Vitro Grown Spirochetes. 
To obtain in vitro log phase spirochetes, all clones were grown in triplicate in 5 ml 
of BSKII medium pH 7.5 at 35°C to a density of 3x107 spirochetes/ml. A total of 1x107 
spirochetes were harvested from each culture and total RNA was isolated using TRIzol 
reagent (Life Technologies) according to the manufacturer’s instructions. RNA was 
resuspended in 100 μl DEPC treated dH2O. RNA was treated with TURBO DNA-free 
(Life Technologies) to remove any contaminating genomic DNA. 1 μl of Riboguard 
(40U/μl) RNAse inhibitor (Epicentre) was added to all samples and RNA stored at            
-80°C. 
3.4.8: Gene Expression Analysis. 
cDNA was synthesized from all RNA samples using the iScript cDNA synthesis 
kit (Bio- Rad) with random primers according to the manufacturer’s instructions. Parallel 
cDNA reactions were carried out in the absence of reverse transcriptase. The cDNA 
was used for end-point PCR amplification using Taq DNA Polymerase with 
ThermoPol® Buffer and 1 µg of cDNA per reaction. Simultaneously quantitative reverse 
transcription PCR (qRT-PCR) reactions were prepared using 1 µg cDNA and iQ SYBR 
Green Supermix (Bio-Rad). Using an Applied Biosystems 7500 instrument, samples 
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were assayed for the vlsE, recA, and bbk46 transcripts using primers pairs 1063 and 
1064, 1123 and 1124, and 1121 and 1122, respectively (Table 9). The recA transcript 
was used as the endogenous reference to which the transcripts of the other genes were 
normalized. The bbk46 and vlsE primers were confirmed to be specific for their gene 
targets. All primers were optimized to maximum efficiency using a standard curve with 
B. burgdorferi genomic DNA at concentrations of 50 ng/µl, 5 ng/µl, 0.5 ng/µl, 0.05 ng/µl, 
and 0.005 ng/µl. The amount of gene specific transcripts were quantitated based upon 
the standard curves generated for each gene and were normalized to recA. Three 
biological replicate samples were analyzed in triplicate and normalized to recA mRNA. 
The amplification of samples lacking reverse transcriptase was similar to that of the no-
template control. 
3.4.9: Complementation Of the ∆bbk46 Mutant With pBSV2G-bbk46ATG-TTT. 
A PCR-based overlap extension strategy was used to introduce a mutation at the 
start codon of the bbk46 gene. The ATG start codon coding for methionine was 
replaced by TTT that codes for phenylalanine. The generated DNA fragment contained 
the rest of bbk46 gene and putative upstream promoter sequence with the introduction 
of a FLAG epitope tag immediately upstream of the putative premature stop codon and 
a C-myc epitope tag immediately upstream of the downstream stop codon.  
The insert with the mutant start codon was generated using pBSV2G-bbk46-
FLAG-C-myc DNA as template, primers 1117 and 1062, 1118 and 1053, and 1119 and 
1120 (Table 9) and Phusion polymerase (New England Biolabs). The PCR products 
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were purified and used to generate the mutant clone in E.coli as described previously 
[158]. The Δbbk46-flaBp-aadA clone was transformed with 20 μg of pBSV2G-bbk46ATG-
TTT-FLAG-C-myc isolated from E. coli and positive transformants selected as previously 
described [16, 74]. The clones that retained the B. burgdorferi plasmid content of the 
parent clone were selected for use in further experiments. 
3.4.10: Immunoblot Analysis of BBK46ATG-TTT.  
Production of the BBK46ATG-TTT-FLAG-cMyc protein was examined in E. coli and 
compared to the production of  BBK46-FLAG-cMyc in E. coli and B. burgdorferi carrying 
pBSV2G bbk46p-bbk46-FLAG-cMyc or pBSV2G flaBp-bbk46-FLAG-cMyc. E. coli protein 
lysates from E.coli carrying plasmids pBSV2G bbk46p-bbk46ATG-TTT-FLAG-cMyc, 
pBSV2G bbk46p-bbk46-FLAG-cMyc and pBSV2G flaBp-bbk46-FLAG-cMyc were 
prepared from 2x109 cells harvested following overnight growth in LB medium at 37°C 
with aeration. E. coli cells were resuspended and lysed in 200 µl B-PER protein 
extraction reagent (Thermo Scientific) followed by the addition of 200 µl 2x Laemmli 
sample buffer plus 2-mercaptoethanol (Bio-rad). Total B. burgdorferi protein lysates 
from clones bbk46p-bbk46-FLAG-cMyc and flaBp-bbk46-FLAG-cMyc were prepared 
from 2x109 spirochetes harvested at mid-log phase.  The spirochetes were washed 
twice in 1 ml cold HN buffer (50 mM Hepes, 50 mM NaCl, pH 7.4) and lysed in 200 µl B-
PER protein extraction reagent (Thermo Scientific), followed by the addition of 200 µl 2x 
Laemmli sample buffer plus 2-mercaptoethanol (Bio-rad). 30 µl of each protein lysate 
(~1.5x108 cells) were separated by SDS-PAGE and transferred to a nitrocellulose 
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membrane. 300 ng of PncA-FLAG [117] protein served as the positive control. 
Immunoblot analysis was performed using anti-FLAG monoclonal primary antibody 
(Genescript) diluted 1:500 in Tris buffered saline, pH 7.4 and 0.5% Tween20 (TBST) 
and goat anti-mouse IgG+IgM-HRP secondary antibody (EMD Milipore) diluted 1:10,000 
in TBST and signal was detected using SuperSignal West Pico chemiluminescent 
substrate kit (Thermo Scientific).  
3.4.1:1 Generation Of Plasmids Containing lp36 Fragments. 
In order to generate the pBSV2*-bbk17 plasmid the bbk17 gene was amplified 
from B. burgdorferi genomic DNA using Phusion High-fidelity DNA polymerase and the 
primers 1125 and 1126 (Table 9). EcoRI restriction sites were introduced at the 5’ and 
3’ends. The EcoRII-digested PCR product was ligated into the EcoRI-digested B. 
burgdorferi shuttle vector pBSV2* [127]. The plasmid structure and sequence were 
confirmed by restriction digest and DNA sequence analysis. Different fragments B, C, 
G, H and I containing genes bbk05, bbk07-bbk08-bbk09, bbk49-bbk50, bbk0059-bbk52-
bbk53 and bbk12-bbk13-bbk15 respectively, of linear plasmid 36 were introduced into a 
shuttle vector pBSV2* [127] containing the bbk17 gene (Fig. 19). The fragments B, C, 
G, H and I were amplified from B. burgdorferi genomic DNA using Phusion High-fidelity 
DNA polymerase and primer pairs 1127 and 1128, 1129 and 1130, 1131 and 1132, 
1133 and 1134, and 1135 and 1136 (Table 9).The fragment B had KpnI restriction sites 
generated at the 5’ and 3’ end and the fragment C had HindIII sites. The fragments G, H 
and K each had sites KpnI at 5’ end and BamHI at the 3’ end. Each of these fragments 
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was digested with the respective restriction enzymes and was then ligated with an 
appropriately digested pBSV2*-bbk17 plasmid. 
B. burgdorferi lacking the entire lp36 plasmid [16] was transformed with 20 μg of 
pBSV2*-bbk17 plasmid isolated from E. coli and positive transformants selected as 
previously described [16, 74].  To facilitate transformation of the shuttle vector plasmids 
into the low-passage lp36- clone background, first high-passage clone B31-A [182] was 
transformed with pBSV2*-bbk17-B ,pBSV2*-bbk17-C,pBSV2*-bbk17-G,pBSV2*-bbk17-
H or pBSV2*-bbk17-I isolated from E.coli. The presence of the shuttle vector plasmids 
was determined by PCR amplification using the primer pairs used to generate the 
respective inserts. The positive transformants were saved at -20oC. Total genomic DNA 
was purified from each of the B31-A clones carrying the shuttle vector plasmids using 
Wizard genomic DNA purification kit (Promega). 1 µg of this DNA was transformed into 
B. burgdorferi lacking the lp36 [16] and positive transformants selected as previously 
described [16, 74]. The clones that retained the B. burgdorferi plasmid content of the 
parent clone were selected for use in further experiments. 
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Table 9: List of primers and probes used in this study 
Primer 
number Designation Sequence (5’ – 3’)
a 
1117 K465’kpn1fwd cggggtaccCTTCCAGTGTAGGCTTTAGTTT 
1118 K463’C-mycSalIrev 
acgcgtcgacTTAcagatcttcttcagaaataagtttttgttcATAAGCAG
CTTCATATGCTTTATTT 
1119 K465’PCR3fwd CGGGGTACCCTTCCAGTGTAG 
1120 K463’PCR3rev ACGCGTCGACTTACAGATCTTCTTCAGAAATA 
1121 Lp3629018F AGCATTATTTGTACTTCTAGGC 
1122 Lp3629013R ACATACTAGACAACAACAAGTC 
1123 recA F AATAAGGATGAGGATTGGTG 
1124 recA R GAACCTCAAGTCTAAGAGATG 
1063 vlsE Express F CTTATACTTTTCATTATAAGGAGACGATG 
1064 vlsE Express R GCCTCTGCTACTAACCCAC 
1061 K46-mut-F 5’ ATAAAGCATAAATATCATCAGATTCTAAGAAGAGGTACTAAGATAGTTTAATTTAATTGC 
1062 K46-mut-R 3’ GCAATTAAATTAAACTATCTTAGTACCTCTTCTTAGAATCTGATGATATTTATGCTTTAT 
1053 bbk45-S 5’BamH1F cgggatccATGTGCAAGCTATATGAAGCTGTAG 
1054 bbk45 3’ Xho1R ccgctcgagCTAAGATTCTCTACTACTTAAAGCAGCTTC 
1045 bbk48-S 5’ BamH1F 
cgggatccATGTGTAAATTATACAAGAAGATTACATACA
ACG 
1046 bbk48 3’ Xho1R ccgctcgagTTATCTAGAGTCCATATCTTGCAATTT 
1043 bbk50-S 5’ BamH1F 
cgggatccATGTGTAAATTATATGAAAAGCTTACAAATAA
ATCGC 
1044 bbk50 3’ Xho1R ccgctcgagTTATCTAGAGTCCATATCTTGCAATTT 
1125 bbk17 EcoRI 5’ cggaattcCTTTGCGCTATAATTTAAGT 
1126 bbk17 EcoRI 3’ cggaattcAAAAACTTTTGAGTTCCTTC 
1127 B05fwdKpnI ggggtaccAACTGGGCATTTTGGTTTACAATTCTAA 
1128 B05revKpnI ggggtaccGCTCATCAAGAATGAAATTCACTATGTTATC 
1129 C07fwdHindIII cccaagcttGGACTGCCAAATTCTCTTAAATTTGAAATT 
1130 C07revHindIII cccaagcttTTAGAATTGTAAACCAAAATGCCCAGTT 
1131 GfwdKpnI ggggtaccGTTGTGTGACATATTCGGTATCTCAAC 
1132 GrevBamHI cgggatccCTAAAGCCTACACTGGAAGTTTTAAAGC 
1133 HfwdKpnI ggggtaccGGTTATTTAGGAGTTCACAGATTTTATGTAGG 
1134 HrevBamHI cgggatccGTTGAGATACCGAATATGTCACACAAC 
1135 K121315fwdKpnI ggggtaccCAAACTGTTTCTGCTGGGAATAAC 
1136 K121315revBamHI cgggatccGATACCAGCAAAGATTATGTGGTAAAG 
1137 flaB-taqman-FWD TCTTTTCTCTGGTGAGGGAGCT 
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Primer 
number Designation Sequence (5’ – 3’)
a 
1138 flaB-taqman-REV TCCTTCCTGTTGAACACCCTCT 
1140 nid1-taqman-FWD CACCCAGCTTCGGCTCAGTA 
1141 nid1-taqman-REV TCCCCAGGCCATCGGT 
1022 C6 Bb F cgggatccCATATGAAGAAGGATGATCAGATTG 
1023 C6 Bb R acgcgtcgacTTACTTCACAGCAAACTTTCCATC 
1143 REVA F cgggatccAAAGCATATGTAGAAGAAAAGAAAG 
1144 REVA R acgcctcgagTTAATTAGTGCCCTCTTCG 
1145 DBPA F cgggatccGGACTAACAGGAGCAACAA 
1146 DBPA R acgcctcgagTTAGTTATTTTTGCATTTTTCATCAG 
1147 BBK19 F cgggatccTTTTCAAAAGATTCTCGATCACG 
1148 BBK19 R acgcctcgagTCAATTGTTAGGTTTTTCTTTTCC 
1149 CRASP2 F cgggatccGATGTTAGTAGATTAAATCAGAGAAATATT 
1150 CRASP2 R cgggatccGATGTTAGTAGATTAAATCAGAGAAATATT 
1151 OSPA F cgggatccAAGCAAAATGTTAGCAGCC 
1152 OSPA R acgcctcgagTTATTTTAAAGCGTTTTTAATTTCATCAAG 
Probe 
number Designation Sequence (5’ – 3’) 
1139 flaB-taqman-Probe 6-FAM-AAACTGCTCAGGCTGCACCGGTTC-TAMRA 
1142 nid1-taqman-Probe 6-FAMCGCCTTTCCTGGCTGACTTGGACA-TAMRA 
aLowercase indicates all non-B. burgdorferi sequence. 
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CHAPTER FOUR: CONCLUSIONS AND FUTURE DIRECTIONS 
Bacterial pathogenesis is the cause of severe, physical, mental and economic 
distress faced by the world today. The effects of bacterial infections range from mild 
fevers, to more debilitating symptoms like tissue necrosis, organ failure or even death. 
Borrelia burgdorferi is an extracellular pathogen that is distinct from many bacterial 
pathogens in the fact that it does not appear to release any known toxins within its host 
to cause disease or tissue damage [1]. B. burgdorferi is known to activate the host 
immune response which, if left activated over long periods of time due to untreated 
infection, can lead to the clinical symptoms of lyme disease [1]. These spirochetes gain 
entry into the mammalian host via the bite of a tick and survive by evading the host 
immune system and scavenging nutrients from the host environment. In order to thrive 
in these hostile conditions, B. burgdorferi has developed strategies of antigenic variation 
to evade the host immune attack and of varying expression of different metabolic genes 
to compensate for changing nutritional availability [1]. Identification of antigenic as well 
as metabolic factors essential for virulence has been a major goal of researchers with 
the aim of gaining better understanding of B burgdorferi pathogenesis. Characteristic 
surface antigens  are used for identification of these spirochetes as part of diagnostic 
kits and can also serve as candidates for vaccine development [185]. However, since B. 
burgdorferi vary their surface complement of proteins throughout the infection cycle 
there is still a pressing need to identify novel makers of infectivity. The studies 
described in the preceding chapters were aimed at investigating the virulence essential 
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linear plasmid 36 and the genes encoded by it so as to identify the factors that 
contribute toward the critical role of this plasmid in B. burgdorferi mammalian infectivity.  
We successfully applied a novel In vivo expression technology (IVET) screen to 
identify B. burgdorferi genes expressed in vivo during murine infection. These results 
represent the first application of IVET to the B. burgdorferi system. We have generated 
a set of candidate promoters that are active in vivo and the associated genes which are 
putative candidates for virulence factors. From the list of in vivo expressed candidate 
genes we proceeded with further investigation of Bbive162 since it was located on the 
virulence essential linear plasmid 36. The data presented herein demonstrate the 
identified in vivo-expressed candidate gene bbk46 to be essential for persistent infection 
within the murine host. These data demonstrate the effectiveness of the IVET screen in 
identifying novel virulence factors and underscore the importance of further investigating 
the other candidates identified by this screen for discovery of new genes essential for 
infectivity. 
 Linear plasmid 36 was previously found to be essential for mammalian infectivity 
and the genes bbk17 and bbk32 have been independently investigated and found to 
contribute, in part, towards successful infection [16, 28, 32]. The identification of bbk46 
as an additional gene that contributes to mammalian infectivity has added another piece 
to this body of knowledge regarding virulence factors on lp36. In the B. burgdorferi clone 
B31, bbk46 gene is annotated as a putative pseudogene due to a premature stop codon 
relative to the sequence of the open reading frame in other B. burgdorferi isolates. We 
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identified that bbk46 did in fact, produce a transcript, both in vivo and in vitro, but no 
protein product was detected in our studies. We also found that, in the absence of 
bbk46, vlsE expression is significantly downregulated and accompanied by loss of long 
term infection in mice, indicating that bbk46 is involved in an, as of yet unknown, 
mechanism of regulation of vlsE expression. Moreover, mutation of the bbk46 start 
codon resulted in no detectable BBK46 protein product but its transcript levels were 
comparable to those of wild-type clones. Surprisingly, the bbk46 mutant allele restored 
vlsE expression to spirochetes lacking the endogenous bbk46 gene. Together these 
data suggest a putative role of bbk46 as a regulatory RNA. This is one of the few 
instances of identification of a putative regulatory RNA molecule in B. burgdorferi and 
lays a foundation for future studies to understand the mechanisms underlying the 
control of genes via such regulatory RNAs. Future studies are aimed at identification of 
the region of the bbk46 allele that is required for regulation of the vlsE expression. At 
present the bbk46 ORF is being analyzed via a truncation approach. A set of shuttle 
vectors containing fragments of the open reading frame are being generated, all having 
the same 5’ end sequence but each fragment of increasing size and sequence at it 3’ 
end so as to incrementally cover the entire ORF. These plasmids will be transformed in 
to B. burgdorferi clones lacking bbk46. The objective is to determine the sequence of 
the bbk46 open reading frame that is necessary and sufficient for the expression of vlsE 
in these clones. We expect that the clone containing the entire ORF will express vlsE 
but as the size of the ORF fragments gets shorter, the sequences will no longer include 
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the region required for expression of the functional bbk46 transcript and the vlsE 
expression will be repressed. Once identified, such a region can be analyzed for 
sequence similarities to other known motifs and secondary structures associated with 
RNA regulation in other organisms and can provide an indication of the function of the 
bbk46 RNA product which can then be further investigated. 
The mechanism of regulation of expression of bbk46 also remains to be 
determined. The expression of the bbk46 gene was found to be increased in 
spirochetes isolated from in vivo samples as compared to in vitro grown spirochetes. 
We also found that bbk46 expression was not RpoS-dependent. Perhaps the induction 
of this gene is influenced by the environment itself. Various host factors such as 
changes in temperature and pH, different cellular and tissue components that interact 
with the invading spirochetes and perhaps even immune response factors might act as 
triggers inducing the increased expression of this critical gene.  Microarray data from 
previous studies looking at the effect of pH and temperature on gene expression have 
not identified bbk46 as being influenced by these factors. In vitro culture of B. 
burgdorferi in the presence of blood or mammalian neuronal or endothelial cells or 
growth in rat dialysis membrane chambers could be carried out to identify host factors 
that might influence the expression of this gene. 
VlsE is a surface antigen that shows antigenic variation and is believed to play an 
essential role in host immune response evasion [13, 14, 18, 85, 86, 90-93]. Identifying 
the involvement of bbk46 in the expression of vlsE introduces the possibility of a novel 
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regulatory mechanism for the expression of this critical antigen and is a highly 
significant contribution from this body of work. We found that spirochetes that lack 
bbk46 also lack detectable vlsE transcripts and are unable to trigger the generation of 
antibodies against the C6 peptide of VlsE within infected mice. One of the most 
surprising findings in this study was that spirochetes lacking the entire lp36 plasmid 
showed no inhibition of vlsE expression even though bbk46 was absent in these clones. 
This suggested the presence of another factor on lp36 that was repressing the 
expression of vlsE in the absence of bbk46 but when the entire lp36 is absent, so is the 
repressor and as a result vlsE expression was uninhibited. In light of these findings, we 
propose a mechanism of regulation of vlsE expression that involves bbk46 as repressor 
of another unknown gene ’x’ located on linear plasmid 36, that in turn, acts as a 
repressor of vlsE (Fig. 21). This putative model of vlsE regulation forms the basis of an 
ongoing investigation aimed at identifying the, as of yet, unknown repressor gene. The 
methodology being used is the construction of a panel of clones lacking the entire lp36 
plasmid and containing bbk17 along with fragments of lp36 that encode its different 
genes (Fig. 19). We expect that the clone containing the repressor gene in the absence 
of the rest of lp36 will cause downregulation of vlsE. Given the fact that vlsE expression 
is crucial for persistent infection in the mammalian host the repressor might be a gene 
showing low expression during mammalian infection as compared to tick colonization or 
it could be a gene that is not differentially expressed throughout the infectious cycle. It is 
possible that bbk46 expression is what influences the activity of the repressor. We have 
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found that bbk46 expression is greatly upregulated in vivo as compared to in vitro. 
Perhaps bbk46 upregulation in vivo causes the repressor to be downregulated thus 
allowing the expression of vlsE. bbk45 is a gene located adjacent to bbk46 on lp36. It is 
a gene of unknown function with some sequence homology to bbk46 and is part of the 
same P37 family of lipoproteins. These features make it a good candidate as a gene 
that might be regulated by bbk46, since it has been observed that non-protein coding 
genes from gene families can regulate the expression of their family members through 
their transcripts [186]. Preliminary studies have identified a few other lp36 encoded 
genes that do not repress vlsE expression. As of now, the putative vlsE repressor 
remains unidentified and is the subject of ongoing investigation.  
The identification of a novel functional gene on the linear plasmid 36 provides 
some more information about the role of this plasmid in mammalian infectivity. However, 
the phenotype of the bbk46 mutant that involves another repressor gene on the same 
plasmid suggests that bbk46 is not the only other factor apart from the previously known 
bbk17 and bbk32 that might be contributing to the importance of lp36. It is also unclear 
whether bbk46 regulation of the repressor gene is direct or there are other intermediate 
factors involved that may or may not be present on lp36. These findings suggest that 
lp36 might have multiple infectivity phenotypes involving different sets of genes. It has 
been observed that addition of bbk17 to an lp36- mutant restored infectivity to the 
mutant in the absence of bbk46 which we have found to be involved in a completely 
different regulation mechanism critical for persistence within the mammalian host. The 
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recent STM study by Lin et al. [26] identified that mutants with disruptions in the genes 
located in the region from bbk02.1 to bbk04 and genes bbk05, bbk07, bbk13, bbk17, 
bbk45, bbk46 to bbk50 on lp36 showed lowered mammalian infectivity. It was 
interesting to note that the P37 family of genes including bbk46 was identified by this 
study to influence infectivity and that they also found bbk17 to influence infectivity as 
had been seen previously [16]. The genes in this list provide a set of valuable gene 
candidates to further investigate for putative roles in B. burgdorferi survival and further 
support the hypothesis that there are additional genes on lp36 that contribute towards 
its infectious phenotype.  
Collectively this body of work introduces IVET as an efficient whole genome 
screening process in B. burgdorferi and identifies a novel virulence factor bbk46 that 
regulates the expression of a critical surface antigen. We have been able to identify a 
novel regulatory mechanism on the essential linear plasmid 36 thereby broadening our 
understanding of the role of this plasmid in mammalian infection. Based on our data we 
propose a putative model of regulation that will guide future investigations aimed at 
improving our understanding of gene regulation in Borrelia burgdorferi.  
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